Advertisements
Feeds:
Posts
Comments

Posts Tagged ‘Systemic inflammatory response syndrome’


A Second Look at the Transthyretin Nutrition Inflammatory Conundrum

Subtitle: Transthyretin and the Systemic Inflammatory Response

 

Author and Curator: Larry H. Bernstein, MD, FACP, Clinical Pathologist, Biochemist, and Transfusion Physician

 

Brief introduction

Transthyretin  (also known as prealbumin) has been widely used as a biomarker for identifying protein-energy malnutrition (PEM) and for monitoring the improvement of nutritional status after implementing a nutritional intervention by enteral feeding or by parenteral infusion. This has occurred because transthyretin (TTR) has a rapid removal from the circulation in 48 hours and it is readily measured by immunometric assay. Nevertheless, concerns have been raised about the use of TTR in the ICU setting, which prompted a review of the  benefit of using this test in acute and chronic care. TTR is easily followed in the underweight and the high risk populations in an ambulatory setting, which has a significant background risk of chronic diseases. It is sensitive to the systemic inflammatory response syndrome (SIRS), and needs to be understood in the context of acute illness to be used effectively. There are a number of physiologic changes associated with SIRS and the injury/repair process that affect TTR. The most important point is that in the context of an ICU setting, the contribution of TTR is significant in a complex milieu.  A much better understanding of the significance of this program has emerged from studies of nitrogen and sulfur in health and disease.

Transthyretin protein structure

Transthyretin protein structure (Photo credit: Wikipedia)

Age-standardised disability-adjusted life year...

Age-standardised disability-adjusted life year (DALY) rates from Protein-energy malnutrition by country (per 100,000 inhabitants). (Photo credit: Wikipedia)

_________________________________________________________________________________________________________

The systemic inflammatory response syndrome C-reactive protein and transthyretin conundrum.
Larry H Bernstein
Clin Chem Lab Med 2007; 45(11):0
ICID: 939932
Article type: Editorial

The Transthyretin Inflammatory State Conundrum
Larry H. Bernstein
Current Nutrition & Food Science, 2012, 8, 00-00

Keywords: Tranthyretin (TTR), systemic inflammatory response syndrome (SIRS), protein-energy malnutrition (PEM), C- reactive protein, cytokines, hypermetabolism, catabolism, repair.

Transthyretin has been widely used as a biomarker for identifying protein-energy malnutrition (PEM) and for monitoring the improvement of nutritional status after implementing a nutritional intervention by enteral feeding or by parenteral infusion. This has occurred because transthyretin (TTR) has a rapid removal from the circulation in 48 hours and it is readily measured by immunometric assay. Nevertheless, concerns have been raised about the use of TTR in the ICU setting, which prompts a review of the actual benefit of using this test in a number of settings. TTR is easily followed in the underweight and the high risk populations in an ambulatory setting, which has a significant background risk of chronic diseases. It is sensitive to the systemic inflammatory response syndrome (SIRS), and needs to be understood in the context of acute illness to be used effectively.

There are a number of physiologic changes associated with SIRS and the injury/repair process that affect TTR and  in the context of an ICU setting, the contribution of TTR is essential.  The only consideration is the timing of initiation since the metabolic burden is sufficiently high that a substantial elevation is expected in the first 3 days post admission, although the level of this biomarker is related to the severity of injury. Despite the complexity of the situation, TTR is not to be considered a test “for all seasons”. In the context of age, prolonged poor meal intake, chronic or acute illness, TTR needs to be viewed in a multivariable lens, along with estimated lean body mass, C-reactive protein, the absolute lymphocyte count, presence of neutrophilia, and perhaps procalcitonin if there is remaining uncertainty. Furthermore, the reduction of risk of associated complication requires a systematized approach to timely identification, communication, and implementation of a suitable treatment plan.

The most important point is that in the context of an ICU setting, the contribution of TTR is significant in a complex milieu.

_________________________________________________________________________________________________________

Title: The Automated Malnutrition Assessment
Accepted 29 April 2012. http://www.nutritionjrnl.com. Nutrition (2012), doi:10.1016/j.nut.2012.04.017.
Authors: Gil David, PhD; Larry Howard Bernstein, MD; Ronald R Coifman, PhD
Article Type: Original Article

Keywords: Network Algorithm; unsupervised classification; malnutrition screening; protein energy malnutrition (PEM); malnutrition risk; characteristic metric; characteristic profile; data characterization; non-linear differential diagnosis

We have proposed an automated nutritional assessment (ANA) algorithm that provides a method for malnutrition risk prediction with high accuracy and reliability.  The problem of rapidly identifying risk and severity of malnutrition is crucial for minimizing medical and surgical complications. These are not easily performed or adequately expedited. We characterized for each patient a unique profile and mapped similar patients into a classification. We also found that the laboratory parameters were sufficient for the automated risk prediction.

_________________________________________________________________________________________________________

Title: The Increasing Role for the Laboratory in Nutritional Assessment
Article Type: Editorial
Section/Category: Clinical Investigation
Accepted 22 May 2012. http://www.elsevier.com/locate/clinbiochem.
Clin Biochem (2012), doi:10.1016/j.clinbiochem.2012.05.024
Keywords: Protein Energy Malnutrition; Nutritional Screening; Laboratory Testing
Author: Dr. Larry Howard Bernstein, MD

The laboratory role in nutritional management of the patient has seen remarkable growth while there have been dramatic changes in technology over the last 25 years, and it is bound to be transformative in the near term. This editorial is an overview of the importance of the laboratory as an active participant in nutritional care.

The discipline emerged divergently along separate paths with unrelated knowledge domains in physiological chemistry, pathology, microbiology, immunology and blood cell recognition, and then cross-linked emerging into clinical biochemistry, hematology-oncology, infectious diseases, toxicology and therapeutics, genetics, pharmacogenomics, translational genomics and clinical diagnostics.

In reality, the more we learn about nutrition, the more we uncover of metabolic diversity of individuals, the family, and societies in adapting and living in many unique environments and the basic reactions, controls, and responses to illness. This course links metabolism to genomics and individual diversity through metabolomics, which will be enlightened by chemical and bioenergetic insights into biology and translated into laboratory profiling.

Vitamin deficiencies were discovered as clinical entities with observed features as a result of industrialization (rickets and vitamin D deficiency) and mercantile trade (scurvy and vitamin C)[2].  Advances in chemistry led to the isolation of each deficient “substance”.  In some cases, a deficiency of a vitamin and what is later known as an “endocrine hormone” later have confusing distinctions (vitamin D, and islet cell insulin).

The accurate measurement and roles of trace elements, enzymes, and pharmacologic agents was to follow within the next two decades with introduction of atomic absorption, kinetic spectrophotometers, column chromatography and gel electrophoresis.  We had fully automated laboratories by the late 1960s, and over the next ten years basic organ panels became routine.   This was a game changer.

Today child malnutrition prevalence is 7 percent of children under the age of 5 in China, 28 percent in sub-Saharan African, and 43 percent in India, while under-nutrition is found mostly in rural areas with 10 percent of villages and districts accounting for 27-28 percent of all Indian underweight children. This may not be surprising, but it is associated with stunting and wasting, and it has not receded with India’s economic growth. It might go unnoticed viewed alongside a growing concurrent problem of worldwide obesity.

The post WWII images of holocaust survivors awakened sensitivity to nutritional deprivation.

In the medical literature, Studley [HO Studley.  Percentage of weight loss. Basic Indicator of surgical risk in patients with chronic peptic ulcer.  JAMA 1936; 106(6):458-460.  doi:10.1001/jama.1936.02770060032009] reported the association between weight loss and poor surgical outcomes in 1936.  Ingenbleek et al [Y Ingenbleek, M De Vissher, PH De Nayer. Measurement of prealbumin as index of protein-calorie malnutrition. Lancet 1972; 300[7768]: 106-109] first reported that prealbumin (transthyretin, TTR) is a biomarker for malnutrition after finding very low TTR levels in African children with Kwashiorkor in 1972, which went unnoticed for years.  This coincided with the demonstration by Stanley Dudrick  [JA Sanchez, JM Daly. Stanley Dudrick, MD. A Paradigm ShiftArch Surg. 2010; 145(6):512-514] that beagle puppies fed totally through a catheter inserted into the superior vena cava grew, which method was then extended to feeding children with short gut.  Soon after Bistrian and Blackburn [BR Bistrian, GL Blackburn, E Hallowell, et al. Protein status of general surgical patients. JAMA 1974; 230:858; BR Bistrian, GL Blackburn, J Vitale, et al. Prevalence of malnutrition in general medicine patients, JAMA, 1976, 235:1567] showed that malnourished hospitalized medical and surgical patients have increased length of stay, increased morbidity, such as wound dehiscence and wound infection, and increased postoperative mortality, later supported by many studies.

Michael Meguid,MD, PhD, founding editor of Nutrition [Elsevier] held a nutrition conference “Skeleton in the Closet – 20 years later” in Los Angeles in 1995, at which a Beckman Prealbumin Roundtable was held, with Thomas Baumgartner and Michael M Meguid as key participants.  A key finding was that to realize the expected benefits of a nutritional screening and monitoring program requires laboratory support. A Ross Roundtable, chaired by Dr. Lawrence Kaplan, resulted in the first Standard of Laboratory Practice Document of the National Academy of Clinical Biochemists on the use of the clinical laboratory in nutritional support and monitoring. Mears then showed a real benefit to a laboratory interactive program in nutrition screening based on TTR [E Mears. Outcomes of continuous process improvement of a nutritional care program incorporating serum prealbumin measurements. Nutrition 1996; 12 (7/8): 479-484].

A later Ross Roundtable on Quality in Nutritional Care included a study of nutrition screening and time to dietitian intervention organized by Brugler and Di Prinzio that showed a decreased length of hospital stay with $1 million savings in the first year (which repeated), which included reduced cost for dietitian evaluations and lower complication rates.

Presentations were made at the 1st International Transthyretin Congress in Strasbourg, France by Mears [E Mears.  The role of visceral protein markers in protein calorie malnutrition. Clin Chem Lab Med 2002; 40:1360-1369] on the impact of TTR in screening for PEM in a public hospital in Louisiana, and by Potter [MA Potter, G Luxton. Prealbumin measurement as a screening tool for patients with protein calorie malnutrition in emergency hospital admissions: a pilot study.  Clin Invest Med. 1999; 22(2):44-52] that indicated a 17% in-hospital mortality rate in a Canadian hospital for patients with PCM compared with 4% without PCM (p < 0.02), while only 42% of patients with PCM received nutritional supplementation. Cost analysis of screening with prealbumin level projected a saving of $414 per patient screened.  Ingenbleek and Young [Y Ingenbleek, VR Young.  Significance of transthyretin in protein metabolism.  Clin Chem Lab Med. 2002; 40(12):1281–1291.  ISSN (Print) 1434-6621, DOI: 10.1515/ CCLM.2002.222, December 2002. published online: 01/06/2005] tied the TTR to basic effects reflected in protein metabolism.

_______________________________________________________________________________________________

Transthyretin as a marker to predict outcome in critically ill patients.
Arun Devakonda, Liziamma George, Suhail Raoof, Adebayo Esan, Anthony Saleh, Larry H Bernstein
Clin Biochem 2008; 41(14-15):1126-1130
ICID: 939927
Article type: Original article

TTR levels correlate with patient outcomes and are an accurate predictor of patient recovery in non-critically ill patients, but it is uncertain whether or not TTR level correlates with level of nutrition support and outcome in critically ill patients. This issue has been addressed only in critically ill patients on total parenteral nutrition and there was no association reported with standard outcome measures. We revisit this in all patients admitted to a medical intensive care unit.

Serum TTR was measured on the day of admission, day 3 and day 7 of their ICU stay. APACHE II and SOFA score was assessed on the day of admission. A registered dietician for their entire ICU stay assessed the nutritional status and nutritional requirement. Patients were divided into three groups based on initial TTR level and the outcome analysis was performed for APACHE II score, SOFA score, ICU length of stay, hospital length of stay, and mortality.

TTR showed excellent concordance with the univariate or multivariate classification of patients with PEM or at high malnutrition risk, and followed for seven days in the ICU, it is a measure of the metabolic burden.  TTR levels decline from day 1 to day 7 in spite of providing nutritional support. Twenty-five patients had an initial TTR serum concentration more than 17 mg/dL (group 1), forty-eight patients had mild malnutrition with a concentration between 10 and 17 mg/dL (group 2), Forty-five patients had severe malnutrition with a concentration less than 10 mg/dL (group 3).  Initial TTR level had inverse correlation with ICU length of stay, hospital length of stay, and APACHE II score, SOFA score; and predicted mortality, especially in group 3.

___________________________________________________________________________________________________________

A simplified nutrition screen for hospitalized patients using readily available laboratory and patient
information.
Linda Brugler, Ana K Stankovic, Madeleine Schlefer, Larry Bernstein
Nutrition 2005; 21(6):650-658
ICID: 825623
Article type: Review article
The role of visceral protein markers in protein calorie malnutrition.
Linda Brugler, Ana Stankovic, Larry Bernstein, Frederick Scott, Julie O’Sullivan-Maillet
Clin Chem Lab Med 2002; 40(12):1360-1369
ICID: 636207
Article type: Original article

The Automated Nutrition Score is a data-driven extension of continuous quality improvement.

Larry H Bernstein
Nutrition 2009; 25(3):316-317
ICID: 939934

______________________________________________________________________________________________________
Transthyretin: its response to malnutrition and stress injury. clinical usefulness and economic implications.
LH Bernstein, Y Ingenbleek
Clin Chem Lab Med 2002; 40(12):1344-1348
ICID: 636205
Article type: Original article

_______________________________________________________________________________________________________

THE NUTRITIONALLY-DEPENDENT ADAPTIVE DICHOTOMY (NDAD) AND STRESS HYPERMETABOLISM
Yves Ingenbleek  MD  PhD  and  Larry Bernstein MD
J CLIN LIGAND ASSAY  (out of print)

The acute reaction to stress is characterized by major metabolic, endocrine and immune alterations. According to classical descriptions, these changes clinically present as a succession of 3 adaptive steps – ebb phase, catabolic flow phase, and anabolic flow phase. The ebb phase, shock and resuscitation, is immediate, lasts several hours, and is characterized by hypokinesis, hypothermia, hemodynamic instability and reduced basal metabolic rate. The catabolic flow phase, beginning within 24 hours and lasting several days, is characterized by catabolism with the flow of gluconeogenic substrates and ketone bodies in response to the acute injury. The magnitude of the response depends on the acuity and the severity of the stress. The last, a reparative anabolic flow phase, lasts weeks and is characterized by the accretion of amino acids (AAs) to rebuilding lean body mass.

The current opinion is that the body economy is reset during the course of stress at novel thresholds of metabolic priorities. This is exemplified mainly by proteolysis of muscle, by an effect on proliferating gut mucosa and lymphoid tissue as substrates are channeled to support wound healing, by altered syntheses of liver proteins with preferential production of acute phase proteins (APPs) and local repair in inflamed tissues (3). The first two stages demonstrate body protein breakdown exceeding the rate of protein synthesis, resulting in a negative nitrogen (N) balance, muscle wasting and weight loss. In contrast, the last stage displays reversed patterns, implying progressive recovery of endogenous N pools and body weight.

These adaptive alterations undergo continuing elucidation. The identification of cytokines, secreted by activated macrophages/monocytes or other reacting cells, has provided further insights into the molecular mechanisms controlling energy expenditure, redistribution of protein pools, reprioritization of syntheses and secretory processes.

The free fraction of hormones bound to specific binding-protein(s) [BP(s)] manifests biological activities, and any change in the BP blood level modifies the effect of the hormone on the end target organ.  The efficacy of these adaptive responses may be severely impaired in protein-energy malnourished (PEM) patients. This is especially critical with respect to changes of the circulating levels of transthyretin (TTR), retinol-binding protein (RBP) and corticosteroid-binding globulin (CBG) conveying thyroid hormones (TH), retinol and cortisol, respectively.  This reaction is characterized by cytokine mediated autocrine, paracrine and endocrine changes. Among the many inducing molecules identified, interleukins 1 and 6 (Il-1, Il-6) and tumor necrosis factor a (TNF) are associated with enhanced production of 3 counterregulatory hormonal families (cortisol, catecholamines and glucagon). Growth hormone (GH) and TH also have roles in these metabolic adjustments.

There is overproduction of cortisol mediated by several cytokines acting on both the adrenal cortex (10) and on the pituitary through hypothalamic CRH with loss of feedback regulation of ACTH production (11). Hypercortisolemia is a major finding observed after surgery (12), sepsis (13), and medical insults, usually correlated with severity of insult and of complications. Rising cortisol values parallel hyperglycemic trends, as an effect of both gluconeogenesis and insulin resistance. Working in concert with TNF, glucocorticoids govern the breakdown of muscle mass, which is regarded as the main factor responsible for the negative N balance.

Under normal conditions, GH exerts both lipolytic and anabolic influences in the whole body economy under the dual control of the hypothalamic hormones somatocrinin (GHRH) and somatostatin (SRIH). GH secretion is usually depressed by rising blood concentrations of glucose and free fatty acids (FFAs) but is paradoxicaly elevated despite hyperglycemia in stressed patients.

The oversecretion of counterregulatory hormones working in concert generates subtle equilibria between glycogenolytic/glycolytic/gluconeogenic adaptive processes. The net result is the neutralization of the main hypoglycemic and anabolic activities of insulin and the development of a persisting and controlled hyperglycemic tone in the stressed body. The molecular mechanisms whereby insulin resistance occurs in the course of stress refer to
cytokine-  and  hormone-induced  phosphorylation abnormalities affecting receptor signaling. The insulin-like anabolic processes of GH are mediated by IGF1 working as relay agent. The expected high IGF1 surge associated with GH oversecretion is not observed in severe stress as plasma values are usually found at the lower limit of normal or even in the subnormal range.  The end result of this dissociation between high GH and low IGF1 levels is to favor the proteolysis of muscle mass to release AAs for gluconeogenesis and the breakdown of adipose tissue to provide ketogenic substrates.

The acute stage of stress is associated with the onset of a low T3 syndrome typically delineated by the drop of both total (TT3) and free (FT3) triiodothyronine plasma levels in the subnormal range. In contrast, both total (TT4) and free (FT4) thyroxine values usually remain within normal ranges with declining trends observed for TT4 and rising tendencies for FT4 (44). This last free compound is regarded as the sensor reflecting the actual thyroid status and governing the release of TSH whereas FT3 works as the active hormonal mediator at nuclear receptor level. The maintenance of an euthyroid sick syndrome is compatible with the down-regulation of most metabolic and energetic processes in healthy tissues. These inhibitory effects , negatively affecting all functional steps of the hypothalamo-pituitary-thyroid axis concern TSH production, iodide uptake, transport and organification into iodotyrosyl residues, peroxidase coupling activity as well as thyroglobulin synthesis and TH leakage. Taken together, the above-mentioned data indicate that the development of hyperglycemia and of insulin-resistance in healthy tissues – mainly in the muscle mass – are hallmarks resulting from the coordinated activities of the counterregulatory hormones.

A growing body of recent data suggest that the stressed territory, whatever the causal agent – bacterial or viral sepsis, auto-immune disorder, traumatic or toxic shock, burns, cancer – manifest differentiated metabolic and immune reactions. The amplitude, duration and efficacy of these responses are reportedly impaired along several ways in PEM patients. These last detrimental effects are accompanied by a number of medical, social and economical consequences, such as extended length of hospital stay and increased complication / mortality rates. It is therefore mandatory to correctly identify and follow up the nutritional status of hospitalized patients. Such approaches are prerequisite to timely and scientifically grounded nutritional and pharmacological mediated interventions.

Contrary to the rest of the body, energy requirements of the inflamed territory are primarily fulfilled by anaerobic glycolysis, an effect triggered by the inhibition of key-enzymes of carbohydrate metabolism, notably pyruvate-dehydrogenase. This non-oxidative combustion of glucose reveals low conversion efficiency but offers the major advantage to maintain, in the context of hyperglycemia, fuel provision to poorly irrigated and/or edematous tissues. The depression of the 5’-monodeiodinating activity (5’-DA) plays a pivotal role in these adaptive changes, yielding inactive reverse T3 (rT3) as index of impaired T4 to T3 conversion rates, but at the same time there is an augmented supply of bioactive T3 molecules and local overstimulation of thyro-dependent processes characterized by thyroid down-regulation.  The same differentiated evolutionary pattern applies to IGF1. In spite of lowered plasma total concentrations, the proportion of IGF1 released in free form may be substantially increased owing to the proteolytic degradation of IGFBP-3 in the intravascular compartment. The digestion of  BP-3 results from the surge of several proteases occurring the course of stress, yielding biologically active IGF1 molecules available for the repair of damaged tissues. In contrast, healthy receptors oppose a strong resistance to IGF1 ligands freed in the general circulation, likely induced by an acquired phosphorylation defect very similar in nature to that for the insulin transduction pathway.

PEM is the generic denomination of a broad spectrum of nutritional disorders, commonly found in hospital settings, and whose extreme poles are identified as marasmus and kwashiorkor. The former condition is usually regarded as the result of long-lasting starvation leading to the loss of lean body mass and fat reserves but relatively well-preserved liver function and immune capacities. The latter condition is typically the consequence of (sub)acute deprivation predominantly affecting the protein content of staplefood, an imbalance causing hepatic steatosis, fall of visceral proteins, edema and increased vulnerability to most stressful factors. PEM may be hypometabolic or hypermetabolic, usually coexists with other diseased states and is frequently associated with complications. Identification of PEM calls upon a large set of clinical and analytical disciplines comprising anthropometry, immunology, hematology and biochemistry.

CBG, TTR and RBP share in common the transport of specific ligands exerting their metabolic effects at nuclear receptor level. Released from their specific BPs in free form, cortisol, FT4 and retinol immediately participe to the strenghtening of the positive and negative responses to stressful stimuli. CBG is a relatively weak responder to short-term nutritional influences (73)  although long-lasting PEM is reportedly capable of causing its significant diminution (74). The dramatic drop of CBG in the course of stress appears as the combined effect of Il-6-induced posttranscriptional blockade of its liver synthesis (75) and peripheral overconsumption by activated neutrophils (61). The divergent alterations outlined by CBG and total cortisolemia result in an increased disposal of free ligand reaching proportions considerably higher than the 4 % recorded under physiological conditions.

The appellation of negative APPs that was once given to the visceral group of carrier-proteins. The NDAD concept takes the opposite view, defending the opinion that their suppressed synthesis releases free ligands which positively contribute to strengthen all aspects of the stress reaction, justifying the ABR denomination. This implies that the role played by ABRs should no longer be interpreted in terms of concentrations but in terms of functionality.

++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++

THE OXIDATIVE STRESS OF HYPERHOMOCYSTEINEMIA RESULTS FROM REDUCED BIOAVAILABILITY OF SULFUR-CONTAINING REDUCTANTS.
Yves Ingenbleek. The Open Clinical Chemistry Journal, 2011, 4, 34-44.

Vegetarian subjects consuming subnormal amounts of methionine (Met) are characterized by subclinical protein malnutrition causing reduction in size of their lean body mass (LBM) best identified by the serial measurement of plasma transthyretin (TTR). As a result, the transsulfuration pathway is depressed at cystathionine-β-synthase (CβS) level triggering the upstream sequestration of homocysteine (Hcy) in biological fluids and promoting its conversion to Met. Maintenance of beneficial Met homeostasis is counterpoised by the drop of cysteine (Cys) and glutathione (GSH) values downstream to CβS causing in turn declining generation of hydrogen sulfide (H2S) from enzymatic sources. The biogenesis of H2S via non-enzymatic reduction is further inhibited in areas where earth’s crust is depleted in elemental sulfur (S8) and sulfate oxyanions. Combination of subclinical malnutrition and S8-deficiency thus maximizes the defective production of Cys, GSH and H2S reductants, explaining persistence of unabated oxidative burden. The clinical entity increases the risk of developing cardiovascular diseases (CVD) and stroke in underprivileged plant-eating populations regardless of Framingham criteria and vitamin-B status. Although unrecognized up to now, the nutritional disorder is one of the commonest worldwide, reaching top prevalence in populated regions of Southeastern Asia. Increased risk of hyperhomocysteinemia and oxidative stress may also affect individuals suffering from intestinal malabsorption or westernized communities having adopted vegan dietary lifestyles.

Metabolic pathways: Met molecules supplied by dietary proteins are submitted to TM processes allowing to release Hcy which may in turn either undergo Hcy – Met RM pathways or be irreversibly committed into TS decay. Impairment of CbS activity, as described in protein malnutrition, entails supranormal accumulation of Hcy in body fluids, stimulation of activity and maintenance of Met homeostasis. This last beneficial effect is counteracted by decreased concentration of most components generated downstream to CbS, explaining the depressed CbS- and CbL-mediated enzymatic production of H2S along the TS cascade. The restricted dietary intake of elemental S further operates as a limiting factor for its non-enzymatic reduction to H2S which contributes to downsizing a common body pool. Combined protein- and S-deficiencies work in concert to deplete Cys, GSH and H2S from their body reserves, hence impeding these reducing molecules to properly face the oxidative stress imposed by hyperhomocysteinemia.

see also …

McCully, K.S. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am. J. Pathol., 1996, 56, 111-128.

Cheng, Z.; Yang, X.; Wang, H. Hyperhomocysteinemia and endothelial dysfunction. Curr. Hypertens. Rev., 2009, 5,158-165.

Loscalzo, J. The oxidant stress of hyperhomocyst(e)inemia. J. Clin.Invest., 1996, 98, 5-7.

Ingenbleek, Y.; Hardillier, E.; Jung, L. Subclinical protein malnutrition is a determinant of hyperhomocysteinemia. Nutrition, 2002, 18, 40-46.

Ingenbleek, Y.; Young, V.R. The essentiality of sulfur is closely related to nitrogen metabolism: a clue to hyperhomocysteinemia. Nutr. Res. Rev., 2004, 17, 135-153.

Hosoki, R.; Matsuki, N.; Kimura, H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun., 1997, 237, 527-531.

Tang, B.; Mustafa, A.; Gupta, S.; Melnyk, S.; James S.J.; Kruger, W.D. Methionine-deficient diet induces post-transcriptional downregulation of cystathionine-􀀁-synthase. Nutrition, 2010, 26, 1170-1175.

Elshorbagy, A.K.; Valdivia-Garcia, M.; Refsum, H.; Smith, A.D.; Mattocks, D.A.; Perrone, C.E. Sulfur amino acids in methioninerestricted rats: Hyperhomocysteinemia. Nutrition, 2010, 26, 1201- 1204.

_______________________________________________________________________________________________________

Yves Ingenbleek. Plasma Transthyretin Reflects the Fluctuations of Lean Body Mass in Health and Disease. Chapter 20. In S.J. Richardson and V. Cody (eds.), Recent Advances in Transthyretin Evolution, Structure and Biological Functions, DOI: 10.1007/978‐3‐642‐00646‐3_20, # Springer‐Verlag Berlin Heidelberg 2009.

Transthyretin (TTR) is a 55-kDa protein secreted mainly by the choroid plexus and the liver. Whereas its intracerebral production appears as a stable secretory process allowing even distribution of intrathecal thyroid hormones, its hepatic synthesis is influenced by nutritional and inflammatory circumstances working concomitantly. Both morbid conditions are governed by distinct pathogenic mechanisms leading to the reduction in size of lean body mass (LBM). The liver production of TTR integrates the dietary and stressful components of any disease spectrum, explaining why it is the sole plasma protein whose evolutionary patterns closely follow the shape outlined by LBM fluctuations. Serial measurement of TTR therefore provides unequalled information on the alterations affecting overall protein nutritional status. Recent advances in TTR physiopathology emphasize the detecting power and preventive role played by the protein in hyperhomocysteinemic states, acquired metabolic disorders currently ascribed to dietary restriction in water-soluble vitamins. Sulfur (S)-deficiency is proposed as an additional causal factor in the sizeable proportion of hyperhomocysteinemic patients characterized by adequate vitamin intake but experiencing varying degrees of nitrogen (N)-depletion. Owing to the fact that N and S coexist in plant and animal tissues within tightly related concentrations, decreasing LBM as an effect of dietary shortage and/or excessive hypercatabolic losses induces proportionate S-losses. Regardless of water-soluble vitamin status, elevation of homocysteine plasma levels is negatively correlated with LBM reduction and declining TTR plasma levels. These findings occur as the result of impaired cystathionine-b-synthase activity, an enzyme initiating the transsulfuration pathway and whose suppression promotes the upstream accumulation and remethylation of homocysteine molecules. Under conditions of N- and S-deficiencies, the maintenance of methionine homeostasis indicates high metabolic priority.

Schematically, the human body may be divided into two major compartments, namely fat mass (FM) and FFM that is obtained by substracting
FM from body weight (BW). The fat cell mass sequesters about 80% of the total body lipids, is poorly hydrated and contains only small quantities of lean tissues and nonfat constituents. FFM comprises the sizeable part of lean tissues and minor mineral compounds among which are Ca, P, Na, and Cl pools totaling about 1.7 kg or 2.5% of BW in a healthy man weighing 70 kg. Subtraction of mineral mass from FFM provides LBM, a composite aggregation of organs and tissues with specific functional properties. LBM is thus nearly but not strictly equivalent to FFM. With extracellular mineral content subtracted, LBM accounts for most of total body proteins (TBP) and of TBN assuming a mean 6.25 ratio between protein and N content.

SM accounts for 45% of TBN whereas the remaining 55% is in nonmuscle lean tissues. The LBM of the reference man contains 98% of total
body potassium (TBK) and the bulk of total body sulfur (TBS). TBK and TBS reach equal intracellular amounts (140 g each) and share distribution patterns (half in SM and half in the rest of cell mass).  The body content of K and S largely exceeds that of magnesium (19 g), iron (4.2 g) and zinc (2.3 g). The average hydration level of LBM in healthy subjects of all age is 73% with the proportion of the intracellular/extracellular fluid spaces being 4:3. SM is of particular relevance in nutritional studies due to its capacity to serve as a major reservoir of amino acids (AAs) and as a dispenser of gluconeogenic substrates. An indirect estimate of SM size consists in the measurement of urinary creatinine, end-product of the nonenzymatic hydrolysis of phosphocreatine which is limited to muscle cells.

During ageing, all the protein components of the human body decrease regularly. This shrinking tendency is especially well documented for SM  whose absolute amount is preserved until the end of the fifth decade, consistent with studies showing unmodified muscle structure, intracellular K content and working capacit. TBN and TBK are highly correlated in healthy subjects and both parameters manifest an age-dependent curvilinear decline
with an accelerated decrease after 65 years.  The trend toward sarcopenia is more marked and rapid in elderly men than in elderly women decreasing strength and functional capacity. The downward SM slope may be somewhat prevented by physical training or accelerated by supranormal cytokine status as reported in apparently healthy aged persons suffering low-grade inflammation. 2002) or in critically ill patients whose muscle mass undergoes proteolysis and contractile dysfunction.

The serial measurement of plasma TTR in healthy children shows that BP values are low in the neonatal period and rise linearly with superimposable concentrations in both sexes during infant growth consistent with superimposable N accretion and protein synthesis rates. Starting from the sixties, TTR values progressively decline showing steeper slopes in elderly males. The lowering trend seems to be initiated by the attenuation of androgen influences and trophic stimuli with increasing age. The normal human TTR trajectory from birth to death has been well documented by scientists belonging to the Foundation for Blood Research. TTR is the first plasma protein to decline in response to marginal protein restricion, thus working as an early signal warning that adaptive mechanisms maintaining homeostasis are undergoing decompensation.

TTR was proposed as a marker of protein nutritional status following a clinical investigation undertaken in 1972 on protein-energy malnourished (PEM) Senegalese children (Ingenbleek et al. 1972). By comparison with ALB and transferrin (TF) plasma values, TTR revealed a much higher degree of sensitivity to changes in protein status that has been attributed to its shorter biological half-life (2 days) and to its unusual Trp richness (Ingenbleek et al. 1972, 1975a). Transcription of the TTR gene in the liver is directed by CCAAT/enhancer binding protein (C/EBP) bound to hepatocyte nuclear factor 1 (HNF1) under the control of several other HNFs. The mechanism responsible for the suppressed TTR synthesis in PEM-states is a restricted AA and energy supply working as limiting factors (Ingenbleek and Young 2002). The rapidly turning over TTR protein is highly responsive to any change in protein flux and energy supply, being clearly situated on the cutting edge of the equipoise.

LBM shrinking may be the consequence of either dietary restriction reducing protein syntheses to levels compatible with survival or that of cytokine-induced tissue proteolysis exceeding protein synthesis and resulting in a net body negative N balance. The size of LBM in turn determines plasma TTR concentrations whose liver production similarly depends on both dietary provision and inflammatory conditions. In animal cancer models, reduced TBN pools were correlated with decreasing plasma TTR values and provided the same predictive ability. In kidney patients, LBM is proposed as an excellent predictor of outcome working in the same direction as TTR plasma levels.  High N intake, supposed to preserve LBM reserves, reduces significantly the mortality rate of kidney patients and is positively correlated with the alterations of TTR plasma concentrations appearing as the sole predictor of final outcome. It is noteworthy that most SELDI or MALDI workers interested in defining protein nutritional status have chosen TTR as a biomarker, showing that there exists a large consensus considering the BP as the most reliable indicator of protein depletion in most morbid circumstances.

Total homocysteine (tHcy) is a S-containing AA not found in customary diets but endogenously produced in the body of mammals by the enzymatic transmethylation of methionine (Met), one of the eight IAAs supplied by staplefoods. tHcy may either serve as precursor substrate for the synthesis of new Met molecules along the remethylation (RM) pathway or undergo irreversible kidney leakage through a cascade of derivatives defining the transsulfuration (TS) pathway. Hcy is thus situated at the crossroad of RM and TS pathways that are regulated by three water-soluble vitamins (pyridoxine, B6; folates, B9; cobalamins, B12).

Significant positive correlations are found between tHcy and plasma urea and plasma creatinine, indicating that both visceral and muscular tissues undergo proteolytic degradation throughout the course of rampant inflammatory burden. In healthy individuals, tHcy plasma concentrations maintain positive correlations with LBM and TTR from birth until the end of adulthood. Starting from the onset of normal old age, tHcy values become disconnected from LBM control and reveal diverging trends with TTR values. Of utmost importance is the finding that, contrary to all protein
components which are downregulated in protein-depleted states, tHcy values are upregulated.  Hyperhomocysteinemia is an acquired clinical entity characterized by mild or moderate elevation in tHcy blood values found in apparently healthy individuals (McCully 1969). This distinct morbid condition appears as a public health problem of increasing importance in the general population, being regarded as an independent and graded risk factor for vascular pathogenesis unrelated to hypercholesterolemia, arterial hypertension, diabetes and smoking.

Studies grounded on stepwise multiple regression analysis have concluded that the two main watersoluble vitamins account for only 28% of tHcy variance whereas vitamins B6, B9, and B12, taken together, did not account for more than 30–40% of variance. Moreover, a number of hyperhomocysteinemic conditions are not responsive to folate and pyridoxine supplementation. This situation prompted us to search for other causal factors which might fill the gap between the public health data and the vitamin triad deficiencies currently incriminated. We suggest that S – the forgotten element – plays central roles in nutritional epidemiology (Ingenbleek and Young 2004).

Aminoacidemia studies performed in PEM children, adult patients and elderly subjects have reported that the concentrations of plasma IAAs invariably display lowering trends as the morbid condition worsens. The depressed tendency is especially pronounced in the case of tryptophan and for the so-called branched-chain AAs (BCAAs, isoleucine, leucine, valine) the decreases in which are regarded as a salient PEM feature following the direction outlined by TTR (Ingenbleek et al. 1986). Met constitutes a notable exception to the above described evolutionary profiles, showing unusual stability in chronically protein depleted states.

Maintenance of normal methioninemia is associated with supranormal tHcy blood values in PEMadults (Ingenbleek et al. 1986) and increased tHcy leakage in the urinary output of PEM children. In contrast, most plasma and urinary S-containing compounds produced along the TS pathway downstream to CbSconverting step (Fig. 20.1) display significantly diminished values. This is notably the case for cystathionine (Ingenbleek et al. 1986), glutathione, taurine, and sulfaturia. Such distorted patterns are reminiscent of abnormalities defining homocystinuria, an inborn disease of Met metabolism characterized by CbS refractoriness to pyridoxine stimuli, thereby promoting the upstream retention of tHcy in biological fluids. It
was hypothesized more than 20 years ago (Ingenbleek et al. 1986) that PEM is apparently able to similarly depress CbS activity, suggesting that the enzyme is a N-status sensitive step working as a bidirectional lockgate, overstimulated by high Met intake (Finkelstein and Martin 1986) and downregulated under N-deprivation conditions (Ingenbleek et al. 2002). Confirmation that N dietary deprivation may inhibit CbS activity has recently provided. The tHcy precursor pool is enlarged in biological fluids, boosting Met remethylation processes along the RM pathway, consistent with studies showing overstimulation of Met-synthase activity in conditions of protein restriction. In other words, high tHcy plasma concentrations observed in PEM states are the dark side of adaptive mechanisms for maintaining Met homeostasis. This is consistent with the unique role played by Met in the preservation of N body stores.

The classical interpretation that strict vegans, who consume plenty of folates in their diet and manifest nevertheless higher tHcy plasma concentrations than omnivorous counterparts, needs to be revisited. On the basis of hematological and biochemical criteria, cobalamin deficiency is one of the most prevalent vitamin-deficiencies wordwide, being often incriminated as deficient in vegan subjects. It seems, however, likely that its true causal impact on rising tHcy values is substantially overestimated in most studies owing to the modest contribution played by cobalamins on tHcy
variance analyses. In contrast, there exists a growing body of converging data indicating that the role played by the protein component is largely underscored in vegan studies. It is worth recalling that S is the main intracellular anion coexisting with N within a constant mean S:N ratio (1:14.5) in animal tissues and dietary products of animal origin (Ingenbleek 2006). The mean S:N ratio found in plant items ranges from 1:20 to 1:35, a proportion that does not optimally meet human tissue requirements (Ingenbleek 2006), paving the way for borderline S and N deficiencies.

A recent Taiwanese investigation on hyperhomocysteinemic nuns consuming traditional vegetarian regimens consisting of mainly rice, soy products,
vegetables and fruits with few or no dairy items illustrates such clinical misinterpretation (Hung et al. 2002). The authors reported that folates and cobalamins, taken together, accounted for only 28.6% of tHcy variance in the vegetarian cohort whereas pyridoxine was inoperative (Hung et al. 2002). The daily vegetable N and Met intakes were situated highly significantly (p < 0.001) below the recommended allowances for humans (FAO/WHO/United Nations University 1985), causing a stage of unrecognized PEM documented by significantly depressed BCAA plasma
concentrations. Met levels escaped the overall decline in IAAs levels, emphasizing that efficient homeostatic mechanisms operate at the expense of an acquired hyperhomocysteinemic state. The diagnosis of subclinical PEM was missed because the authors ignored the exquisitely sensitive TTR detecting power. A proper PEM identification would have allowed the authors to confirm the previously described TTR–tHcy relationship that was established in Western Africa from comparable field studies involving country dwellers living on plant products.

The concept that acute or chronic stressful conditions may exert similar inhibitory effects on CbS activity and thereby promote hyperhomocysteinemic states is founded on previous studies showing that hypercatabolic states are characterized by increased urinary N and S losses maintaining tightly correlated depletion rates (Cuthbertson 1931; Ingenbleek and Young 2004; Sherman and Hawk 1900) which reflect the S:N ratio found in tissues undergoing cytokine induced proteolysis. This has been documented in coronary infarction and in acute pancreatitis where tHcy elevation evolves too rapidly to allow for a nutritional vitamin B-deficit explanation.  tHcy is considered stable in plasma and the two investigations report unaltered folate and cobalamin plasma concentrations.

The clinical usefulness of TTR as a nutritional biomarker, described in the early seventies (Ingenbleek et al. 1972) has been substantially disregarded by the scientific community for nearly four decades. This long-lasting reluctance expressed by many investigators is largely due to the fact that protein malnutrition and stressful disorders of various causes have combined inhibitory effects on hepatic TTR synthesis. Declining TTR plasma concentrations may result from either dietary protein and energy restrictions or from cytokine-induced transcriptional blockade (Murakami et al. 1988) of its hepatic synthesis. The proposed marker was therefore seen as having high sensitivity but poor specificity. Recent advances in protein metabolism settle the controversy by throwing further light on the relationships between TTR and the N-components of body composition.

The developmental patterns of LBM and TTR exhibit striking similarities. Both parameters rise from birth to puberty, manifest gender dimorphism during full sexual maturity then decrease during ageing. Uncomplicated PEM primarily affects both visceral and structural pools of LBM with distinct kinetics, reducing protein synthesis to levels compatible with prolonged survival. In acute or chronic stressful disorders, LBM undergoes muscle proteolysis exceeding the upregulation of protein syntheses in liver and injured areas, yielding a net body negative N balance. These adaptive responses are well identified by the measurement of TTR plasma concentrations which therefore appear as a plasma marker for LBM fluctuations.
Attenuation of stress and/or introduction of nutritional rehabilitation restores both LBM and TTR to normal values following parallel slopes. TTR fulfills, therefore, a unique position in assessing actual protein nutritional status, monitoring the efficacy of dietetic support and predicting the patient’s outcome (Bernstein and Pleban 1996).

see also…

Acosta PB, Yannicelli S, Ryan AS, Arnold G, Marriage BJ, Plewinska M, Bernstein L, Fox J, Lewis V, Miller M, Velazquez A (2005) Nutritional therapy improves growth and protein status of children with a urea cycle enzyme defect. Mol Genet Metab 86:448–455.

Arroyave G, Wilson D, Be´har M, Scrimshaw NS (1961) Serum and urinary creatinine in children with severe protein malnutrition. Am J Clin Nutr 9:176–179.

Bates CJ, Mansoor MA, van der Pols J, Prentice A, Cole TJ, Finch S (1997) Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over. Eur J Clin Nutr 51:691–697.

Battezzatti A, Bertoli S, San Romerio A, Testolin G (2007) Body composition: An important determinant of homocysteine and methionine concentrations in healthy individuals. Nutr Metab Cardiovasc Dis 17:525–534.

Bernstein LH, Bachman TE, Meguid M, Ament M, Baumgartner T, Kinosian B, Martindale R, Spiekerman M (1995) Prealbumin in nutritional care Consensus Group. Measurement of visceral protein status in assessing protein and energy malnutrition: Standard of care. Nutrition 11:169–171

Bernstein LH, Ingenbleek Y (2002) Transthyretin: Its response to malnutrition and stress injury. Clinical usefulness and economical implications. Clin Chem Lab Med 40:1344–1348.

Boorsook H, Dubnoff JW (1947) The hydrolysis of phosphocreatine and the origin of creatinine. J Biol Chem 168:493–510.

Briend A, Garenne M, Maire B, Fontaine O, Dieng F (1989) Nutritional status, age and survival: The muscle mass hypothesis. Eur J Clin Nutr 43:715–726

Brouillette J, Quirion R (2007) Transthyretin: A key gene involved in the maintenance of memory capacities during aging. Neurobiol Aging 29:1721–1732

Chertow GM, Goldstein-Fuchs DJ, Lazarus JM, Kaysen GA (2005) Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients. Kidney Int 68:2794–2800

Cohn SH, Gartenhaus W, Sawitsky A, Rai K, Zanzi I, Vaswani A, Ellis KJ, Yasumura S, Cortes E, Vartsky D (1981) Compartmental body composition of cancer patients by measurement of total body nitrogen, potassium and water. Metabolism 30:222–229

Cuthbertson DP (1931) The distribution of nitrogen and sulphur in the urine during conditions of increased catabolism. Biochem J 25:236–244

Devakonda A, George L, Raoof S, Esan A, Saleh A, Bernstein LH (2008) Transthyretin as a marker to predict outcome in critically ill patients. Clin Biochem 41:1126–1130

Ellis KJ, Yasumura S, Vartsky D, Vaswani AN, Cohn SH (1982) Total body nitrogen in health and disease: Effects of age, weight, height, and sex. J Lab Clin Med 99:917–926

Etchamendy N, Enderlin V, Marighetto A, Vouimba RM, Pallet V, Jaffard R, Higueret P (2001) Alleviation of a selective age-related relational memory deficit in mice by pharmacologically induced normalization of brain retinoid signaling. J Neurosci 21:6423–6429

Evans WJ (1991) Reversing sarcopenia: How weight training can build strength and vitality. Geriatrics 51:46–53

Evans WJ, Campbell WW (1993) Sarcopenia and age-related changes in body composition and functional capacity. J Nutr 123:465–468

Finkelstein JD, Martin JJ (1984) Methionine metabolism in mammals. Distribution of methionine between competing pathways. J Biol Chem 259:9508–9513

Garg UC, Zheng ZJ, Folsom AR, Moyer YS, Tsai MY, McGovern P, Eckfeldt JH (1997) Short-term and long-term variability of plasma homocysteine measurement. Clin Chem 43:141–145

Goodman AB, Pardee AB (2003) Evidence for defective retinoid transport and function in late onset Alzheimer’s disease. Proc Natl Acad Sci USA 100:2901–2905

Gray GE, Landel AM, Meguid MM (1994) Taurine-supplemented total parenteral nutrition and taurine status of malnourished cancer patients. Nutrition 10:11–15

Heymsfield SB, McManus C, Stevens V, Smith J (1982) Muscle mass: Reliable indicator of protein-energy malnutrition and outcome. Am J Clin Nutr 35:1192–1199

Ingenbleek Y (2006) The nutritional relationship linking sulfur to nitrogen in living organisms. J Nutr 136:S1641–S1651
Ingenbleek Y (2008) Plasma transthyretin indicates the direction of both nitrogen balance and retinoid status in health and disease. Open Clin Chem J 1:1–12
Ingenbleek Y, Bernstein LH (1999a) The stressful condition as a nutritionally dependent adaptive dichotomy. Nutrition 15:305–320
Ingenbleek Y, Bernstein LH (1999b) The nutritionally dependent adaptive dichotomy (NDAD) and stress hypermetabolism. J Clin Ligand Assay 22:259–267
Ingenbleek Y, Carpentier YA (1985) A prognostic inflammatory and nutritional index scoring critically ill patients. Internat J Vitam Nutr Res 55:91–101

Ingenbleek Y, Young VR (1994) Transthyretin (prealbumin) in health and disease: Nutritional implications. Annu Rev Nutr 14:495–533
Ingenbleek Y, Young VR (2002) Significance of transthyretin in protein metabolism. Clin Chem Lab Med 40:1281–1291
Ingenbleek Y, Young VR (2004) The essentiality of sulfur is closely related to nitrogen metabolism. Nutr Res Rev 17:135–151

Pharma Intell Links

Nitric Oxide and iNOS have Key Roles in Kidney Diseases – Part II
Biochemistry of the Coagulation Cascade and Platelet Aggregation – Part I 
Mitochondrial dynamics and cardiovascular diseases 
“Seductive Nutrition”: Making Popular Dishes a Bit Healthier – Culinary Institute of America
Low Bioavailability of Nitric Oxide due to Misbalance in Cell Free Hemoglobin in Sickle Cell Disease – A Computational Model
Ubiquinin-Proteosome pathway, autophagy, the mitochondrion, proteolysis and cell apoptosis
Nitric Oxide and Immune Responses: Part 2
Mitochondrial Damage and Repair under Oxidative Stress
Endothelial Function and Cardiovascular Disease
Nitric Oxide and Sepsis, Hemodynamic Collapse, and the Search for Therapeutic Options
Is the Warburg Effect the cause or the effect of cancer: A 21st Century View?
Sepsis, Multi-organ Dysfunction Syndrome, and Septic Shock: A Conundrum of Signaling Pathways Cascading Out of Control
Mitochondria: Origin from oxygen free environment, role in aerobic glycolysis, metabolic adaptation
Metabolite Identification Combining Genetic and Metabolic Information: Genetic association links unknown metabolites to functionally related genes
Clinical Trials Results for Endothelin System: Pathophysiological role in Chronic Heart Failure, Acute Coronary Syndromes and MI – Marker of Disease Severity or Genetic Determination?
Nitric Oxide Covalent Modifications: A Putative Therapeutic Target?

Advertisements

Read Full Post »


A model approach

Larry H. Bernstein, MD

Executive Summary:

Sepsis is the most costly diagnosis in hospitalized patients and carries a high financial risk as a comorbidity and payment penalty under the new severity of illness CMS reimbursement guidelines as a patient safety hazard for failure to diagnose in a timely manner.  We carried out two studies of the early recognition of sepsis and related diseases in patients seen in the emergency department related to admission to the intensive care unit (ICU)(New YorkMethodistHospital) under the leadership of Lawrence Melniker, MD, Chairman of the Pharmacy and Therapeutics Committee.  The widely used SIRS criteria and the C-reactive protein, a long established acute phase protein, are each by themselves insufficient because of the low false negative rate of the former and the skewness and long tail of the latter related to uncurtailed noise from inconsequential inflammatory disease.  Using the elevated neutrophil count and left shift has proved to be elusive as well.  We and many others have established the validity of the European studies showing a marked benefit from using the procalcitonin (PCT, Brahms), and we propose to seize on the opportunity to calibrate the measurement of granulocyte maturation to the PCT.  The study would have to be carried out on a Sysmex instrument for accuracy and ease of use.  The Sysmex IG parameter is a measure of immature granulocyte counts and includes metamyelocytes, myelocytes and promyelocytes.

Background Study

Neutrophils thought to play a significant role in the early microvascular changes, are thought to be a key factor in the evolution of organ failure in the pathogenesis of severe sepsis and septic shock.  The mechanism of action of any drug or combination antibiotic combination therapy could potentially influence IG responses so that IG may be a useful way to monitor responses to therapy and disease progression by a simple, widely used hemocytometer that incorporates flow cytometry for cell identification.

An evaluation of the diagnostic performance of the Sysmex IG parameter and the procalcitonin (PCT, Brahms) assays when compared to existing practices and treatment decision guidelines is proposed following the establishment of a validated of a critical-decision cutoff for patients over 6 years old of 2.8% +0.2%.  Statistically significant numbers of samples representing the following patient groups would be assessed:

Group 1: Patients presenting to ICU with suspected Infection, SIRS (Systemic Inflammatory Response Syndrome, or severe sepsis, who are subjected to standard clinical and diagnostic investigation and do not fulfill criteria that warrant treatment with  antibiotic for the assessed state.

Group 2: Patients presenting to ICU with suspected Infection, SIRS (Systemic Inflammatory Response Syndrome, or severe sepsis, who are subjected to standard clinical and diagnostic investigation and are placed on antibiotic therapy (Infection) as a result of the investigation.

Group 3: Patients presenting to ICU with suspected Infection, SIRS (Systemic Inflammatory Response Syndrome, or severe sepsis, who are subjected to standard clinical and diagnostic investigation and are classified as having SIRS (Systemic Inflammatory Response Syndrome according to the equivalent of New York Methodist Hospital classification of SEPSIS (based on a modified Xigris (discontinue by Lilly) screening criteria, irrespective of the treatment option followed.

Group 4: Patients presenting to ICU with suspected Infection, SIRS (Systemic Inflammatory Response Syndrome, or severe sepsis, who are subjected to standard clinical and diagnostic investigation and have evidence of organ failure (New York Methodist Hospital classification of SEVERE SEPSIS; Xigris screening criteria for ACUTE ORGAN DYSFUNCTION.)

Diagnostic performance of both the Sysmex IG parameter and the procalcitonin (PCT, Brahms) assays are to be assessed as tools for sub-classification according to existing practices.

The ability of the IG parameter to detect the myeloid response associated prior to and increased with the onset of microvascular damage will be assessed. The potential to detect the IG response to predict progression towards multiple organ dysfunction could be an indication to initiate pharmacological therapy at a stage prior to significant evidence of organ failure.

The potential to use the IG parameter as a tool for monitoring responses to antibiotic and single or combination therapy could be assessed if the increase in IG shows good diagnostic performance alone or in combination as a necessary feature for decision-making.

 

SCREENING PATIENTS FOR SEVERE SEPSIS

 

http://www.xigris.com/140-screening-guide.jsp

 

GROUP 2: INFECTION–Does your patient have one or more of the following infection criteria?

  • Documented or Suspected–Does the patient have positive culture results (from blood, sputum, urine, etc.)?
  • Anti-Infective Therapy–Is the patient receiving antibiotic, antifungal, or other anti-infective therapy?
  • Pneumonia–Is there documentation of pneumonia (x-ray, etc.)?
  • WBCs–Have WBCs been found in normally sterile fl uid (urine, CSF, etc.)?
  • Perforated Viscus–Does the patient have perforated hollow organ (bowel)?
  • GROUP 3: SIRS-Does your patient have two or more of the following SIRS criteria?
  • Temperature–Is the patient’s temperature > 38°C (> 100.4°F) or < 36°C (< 96.8°F)?
  • Heart Rate–Is the patient’s heart rate > 90 bpm?
  • Respiratory Rate–Is the patient’s respiratory rate > 20 breaths/min?
  • WBC Count–Is the patient’s WBC count > 12,000/mm3, < 4000/mm3, absolute neutrophil count > 11,000/mm3, or are there > 2.8% immature granulocytes (myelocytes and metamyelocytes) discounting 10% band neutrophils and the less mature promyelocytes for left shift?
  • GROUP 4: ACUTE ORGAN DYSFUNCTION-Does your patient have one or more of the following organ dysfunction critera?
  • Cardiovascular–Does the patient have a systolic BP ≤ 90 mmHg or mean arterial pressure ≤ 70 mmHg (for at least 1 hour despite fl uid resuscitation) or require vasopressor support?
  • Respiratory–Does the patient have a PaO2/FiO2 ratio ≤ 250, PEEP > 7.5 or require mechanical ventilation?
  • Renal–Does the patient have low urine output (eg, <0.5 mL/kg/hr for 1 hour despite adequate fl uid rescuscitation),
  • increased creatinine (>50% increase from baseline) or require acute dialysis?
  • Hematologic–Does the patient have a low platelet count (< 100,000/mm3) or PT/PTT > upper limit of normal?
  • Metabolic–Does the patient have a low pH with high lactate (eg, pH < 7.30 and plasma lactate > upper limit of normal?
  • Hepatic–Are the patient’s liver enzymes > 2x upper limit of normal?
  • CNS-Does the patient have altered consciousness or reduced Glasgow Coma Score?

Guidelines For Management

Sepsis, Severe Sepsis, and Septic Shock

A. Definitions

Sepsis

Presence or Suspicion of infection and one or more of the following conditions

  • Fever (core temperature >38.3°C)
  • Hypothermia (core temperature <36°C)
  • Heart rate >90/min or >2 SD above the normal value for age
  • Tachypnea > 20/min or >2 SD above the normal value for age
  • Altered mental status
  • Leukocytosis (WBC count >12,000/µL)
  • Leukopenia (WBC count <4000/µL)
  • Neutrophilia as defined above
  • Normal WBC count with >2.8% immature granulocytes (IG)

 

Severe Sepsis

Sepsis and at least one New Organ Dysfunction

Organ dysfunction variables:

  • Altered level of consciousness or reduced Glasgow coma score
  • Arterial hypoxemia (PaO2/FIO2 <300)
  • Acute oliguria – urine output <0.5 mL/kg/hr)
  • Creatinine > 2.0 mg/dL or > 50% increase from baseline
  • Coagulation abnormalities (INR >1.5 or aPTT >60 secs)
  • Thrombocytopenia (Platelet count <100,000/µL)
  • Hyperbilirubinemia (Plasma total bilirubin > 2.0 mg/dL or 35 mmol/L)

 

Tissue perfusion variables:

  • Hyperlactatemia (>2 mmol/L)
  • Metabolic acidosis  ( pH < 7.30)

 

Hemodynamic variables:

  • Transient arterial hypotension (SBP <90, MAP <70, or SBP decrease >40 mm Hg from baseline) (Hypotension corrected with adequate volume resuscitation)

 

Septic Shock

Severe Sepsis and Persistent Arterial Hypotension

Screening Tool for Sepsis

Emergency Department, Med-Surg Floors, and Critical Care Units

 

1. Is the patient’s history suggestive of a NEW infection?                                                             ___ Yes ___No

 

[Check any that apply]

   
Pneumonia or Empyema

(  )

Skin/soft tissue infection

(  )

Urinary tract infection

(  )

Wound infection

(  )

Acute abdominal infection

(  )

Bone/joint infection

(  )

Meningitis

(  )

Bloodstream catheter

(  )

Endocarditis

(  )

Implantable device

(  )

Other

(  )

   

           

2. Are any two of the following signs, symptoms, or findings of infection

*both* – Present and New – to the patient?                                                                                    ___ Yes ___No

 

[Check any that apply]

     
Hyperthermia

> 38.3 °C (101.0 oF)

Hypothermia

< 36 °C     (96.8°F)

(  )

(  )

Leukocytosis

(WBC count >12,000/µL)

Leukopenia

(WBC count <4000/µL)

(  )

(  )

Tachycardia > 90 bpm

Tachypnea > 20 bpm

Altered mental status

(  )

(  )

(  )

Hyperglycemia

(serum glucose >120 mg/dL

– in the absence of diabetes)

(  )

If The Answer Is “YES” To BOTH Questions 1 And 2,

 

è  SUSPICION of INFECTION is Present:

 

  • Immediately obtain:
    • CBC with differential
    • Comprehensive metabolic panel
    • Procalcitonin
    • C-reative protein (CRP)
    • Lactate level
    • ABG
    • Blood cultures
    • Liver function tests
    • Coagulation profile
    • Urine analysis
    • CXR
    • Pulse co-oximetry

3. Are any of the following organ dysfunctioncriteria *both* – Present & New – in an organ remote from the site of the infection? 

___ Yes ___No

 

 

Organ Dysfunction Criteria

 

  • SBP < 90 mmHg or MAP < 65 mmHg
  • SBP decrease > 40 mm Hg from baseline
  • Bilateral pulmonary infiltrates with a:
New or increased O2 supplementation requirement to maintain SpO2 > 90%   OR
  • PaO2/FiO2 ratio < 300
  • Creatinine > 2.0 mg/dl (176.8 mmol/L)
  • Urine Output < 0.5 ml/kg/hour for > 2 hours
  • Bilirubin > 2 mg/dl (34.2 mmol/L)
  • Platelet count < 100,000
  • Coagulopathy (INR >1.5 or aPTT >60 secs)
  • Lactate > 2 mmol/L (18.0 mg/dl)
 

Note: the remote organ stipulation is waived in the case of bilateral pulmonary infiltrates

 

If suspicion of infection AND organ dysfunctionare present,

the patient meets the criteria for SEVERE SEPSIS

 

èInitiate severe sepsis protocol to achieve these goals <6 hrs

 

 

6-Hr Goals for Severe Sepsis
1)    Mean arterial pressure > 65 mm of Hg
2)    Urine output > 0.5 ml/kg/hr [average sized adult > 30-40 cc/hr]
3)    CVP > 8-10 mm Hg or Sonographic Signs of adequate filling pressures
4)    SVO2 > 70%

Early Goal-Directed Therapy for Severe Sepsis

[For Emergency Department / Med-Surg Floors / Critical Care Medicine settings]

 

First 6 hrs

 

  • Severe sepsis identified by screening                 Yes                  No
  • Blood cultures sent                                           Yes                  No
  • Serum lactate sent                                             Yes                 No
  • Patient hypotensive with
    • Systolic Blood Pressure <90 or                   Yes                  No
    • Mean Arterial Pressures < 65 mm of Hg     Yes                  No

0 – 1 hr Management

1)      Start fluid bolus normal saline 20 ml/kg at 500 – 1000ml over 30 minutes and re-evaluate blood pressure and urine output (expected value >0.5ml/kg/hr)

2)      Re-evaluate 10 minutes after fluid bolus

3)      If blood pressure is stabilized, continue fluids at maintenance rate [No CVP Monitoring Needed]

4)      O2 supplementation to maintain SaO2 > 90% — ventilatory support, if indicated

1 – 2 hrs Management

5)      If patient remains hypotensive [Med-Surg MUST Call for CVP Monitoring Approval]

  • ABG, if not done already
  • Measure CVP or Sonographic Signs of adequate filling pressure:                                           When possible:
    • Central Venous Catheterization with
    • Central Venous Pressure Transducer/Monitor

 

 

For CVP < 8-10 mm Hg and MAP < 65 mm Hg

(HYPOTENSION WITHOUT ADEQUATE FILLING PRESSURE)

  • Repeat fluid bolus 20 ml/kg at 500 –1000 ml over 30 minutes until:
    • Patient has CVP > 8-10 mm Hg
      • Continue fluid boluses to correct CVP > 8-10 mm Hg

OR

  • Signs of volume overload on physical examination
  • If patient is unstable
    • May start norepinephrine infusion at this time
 

For CVP > 8-10 mm Hg and MAP < 65 mm Hg

(HYPOTENSION WITH ADEQUATE FILLING PRESSURE)

  • Start norepinephrine infusion to achieve MAP >65 mm Hg

 

1 – 2 hrs Management (continued)

 

6)      Stat antibiotics (suggested agents – adjust for creatinine clearance)

 

  1. a.      Community Acquired Pneumonia  – Follow hospital protocol
  2. b.      Healthcare Associated Pneumonia – Follow hospital protocol
  3. Urinary tract infection (choose one)
    1. Ceftriaxone 1 gm IVPB (Community Acquired)

ii. Cefipime 1 gm IVPB (Hospital Acquired)

  1. Ciprofloxacin 400 mg IVPB (For PCN or Cephalosporin allergy)
  2. Suspected intra-abdominal infection (choose one)
    1. Cefipime 1 gm IVPB and Metronidazole 500 mg IVPB

ii. Ciprofloxacin 400 mg IVPB and Metronidazole 500 mg IVPB

  1. Piperacillin /Tazobactam 3.75 gm IVPB

 

 

2 – 6 hrs Management

6) Admit/Transfer the patient to Critical Care Medicine setting

7) Repeat lactate level in 4 hrs, if lactate > 4 mmol /L:                                                      Measure SVO2

8)  If SVO2 < 70 % & HCT < 30%:                                                                               Consider transfusion of PRBC to achieve HCT > 30%

9) Repeat SVO2 after optimization of CVP > 8-10 mm Hg & HCT > 30%:         Consider inotropic therapy

10) If SVO2 remains < 70%:                                                                                           Start Dobutamine infusion at 5 micrograms/kg/minute

6 –24 hrs Management [Critical Care Medicine]

 

   11) Evaluate for Relative Adrenal Insufficiency:                                                                      Send serum cortisol level and order cosyntropin test

12)While waiting for cortisol level:                                                                                   Start Decadron 4 mg IV

13) For blood sugar > 150 mg/dl:                                                                                                Start Critical Care Medicine Insulin protocol

14) Evaluate for drotrecogin alpha administration:                                                          Use Hospital protocol

15) If patient is on a ventilator, evaluate for ALI/ARDS:                                                  Start ARDS ventilator protocol in appropriative patients

16 If patient remain hypotensive and CVP > 8-10 mm Hg:                                                           Start Vasopressin infusion at 0.04 units per minute

Summary Approach to Problem

Objective: To sub-classify patients presenting to ICU into GROUPS 1-4 as described above, and to record the appropriate treatment decision (Antibiotics, and other).  Statistically significant numbers of patients representing each of the sub-groups will be included in the study.  Diagnostic performance of both the Sysmex IG parameter and the procalcitonin (PCT, Brahms) assays will be assessed as potential tools to differentiate groups 1 from 2, 2 from 3 and 3 from 4.

If the IG and/or procalcitonin tests are deemed valuable as markers of the microvascular damage which precedes multiple organ damage associated with sepsis, the potential exists to motivate for application as an index for the initiation of innovative drug therapy at an earlier stage, in an effort to prevent disease progression to multiple organ failure.  If data supports this change, the potential for monitoring responses to investigated antibiotic therapy in patients with raised IG and / or PCT values should be assessed.

Methods: A prospective, observational study from one or several large community or academically-linked hospitals following IRB requirements. A total of 1000 consecutive patients presenting to ICU with presumed infection/sepsis will be enrolled.  Clinical and diagnostic sub-classification according to groups 1-4 above have to be performed, in conjunction with a Sysmex CBC, Diff and IG, as well as a procalcitonin (PCT, Brahms) assay.

Results:  Statistically significant numbers of patients representing each of the 4 groups will be documented, and their treatment (antibiotic/combination drug) will be recorded.

Statistical assessment: At a minimum, ROC curve analysis of IG (and PCT) versus Group 1-4 classifications will be done. ROC curve analysis of IG (and PCT) versus therapy decisions will also be performed.  If successful, the capability of the parameters to monitor treatment responses will be assessed by serial measurements over time. A method of anomaly characterization developed by Gil David and Prof. Ronald Coifman of Yale University will be applied using key indicators to classify the patients such as WBC, percent neutrophils, IG, PCT, subclass 1-4, treatment, outcome (LOS in ICU, LOS, died).

Study Design:
Type study: Prospective and not interventional
Patient population: 1000 patients, admitted to ICU with suspected severe infection / SIRS / Sepsis.

Diagnostic information: Concurrent information gathered will be in accordance with Xigris Screening recommendations for severe sepsis, and theHospital guidelines for management of sepsis, severe sepsis and septic shock as described above.  Including – respiratory rate, heart rate, fever, location, primary and secondary diagnoses, APACHE score and SOFA score, antibiotic use, target therapy/other use etc.

 

Image

Read Full Post »


The role of biomarkers in the diagnosis of sepsis and patient management

Author: L. H. Bernstein, MD, FCAP

Key words: Systemic Inflammatory Response Syndrome (SIRS), sepsis, septic shock, mean arterial blood pressure (MAP), procalcitonin, combinatorial analysis, effect size

Highlights:
1.   The systemic inflammatory response syndrome (SIRS) is an acute response to trauma, burn, or infectious injury characterized by fever, hemodynamic and respiratory changes, and metabolic changes, not all of which are consistently present.

2.   The SIRS reaction involves hormonally driven changes in liver glycogen reserves, triggering of  lipolysis, lean body proteolysis, and reprioritization of hepatic protein synthesis with up-regulation of synthesis of acute phase proteins and down-regulation of albumin and important circulating transport proteins.

3.   Understanding of the processes leads to the identification of biomarkers for identification of sepsis and severe, moderate or early SIRS, which also can hasten treatment and recovery.

4.   The SIRS reaction unabated leads to a recurring cycle with hemodynamic collapse from septic shock, indistinguishable from cardiogenic shock, and death.

Abbreviations: Systemic Inflammatory Response Syndrome (SIRS), procalcitonin (PCT), C-reactive protein (CRP), mean arterial blood pressure (MAP), Intensive care unit (ICU), total white blood cell count (WBC), transthyretin(TTR)

Summary
By focusing on early and accurate diagnosis of infection in patients suspected of SIRS antibiotic overuse and its associated morbidity and mortality may be avoided, and therapeutic targets may be identified. This discussion investigates the performance of diagnostic algorithms and biomarkers for sepsis in patients presenting with leukocytosis and other findings. Suspected patients are usually identified by WBC above 12,000/mL  PCT level , SIRS and other criteria, such as serum biomarkers of sepsis. In this writer’s study of 435 patients, procalcitonin alone was a superior marker for sepsis. In patients with sepsis there was a marked increase in PCT (p = 0.0001). PCT was increased in patients requiring ICU admission, heart rate and blood pressure monitoring, and assisted ventilation.(p = 0.0001). Means for SIRS/non-SIRS were: CRP 802/404 mg/L; PCT 20.6/7.5 ng/mL; TTR 87.8/125 mg/L. A comprehensive overview of at least a decade of work is provided.

Introduction

Sepsis is a costly diagnosis in hospitalized patients and carries a high financial risk as a comorbidity and a payment penalty for failure to diagnose in a timely manner (1-4) under the severity of illness CMS reimbursement guidelines as a patient safety hazard, with pneumonia and sepsis among the ten most costly among hospital admissions. A polypeptide identical to a prohormone of calcitonin, procalcitonin, was initially described as a potential marker of bacterial disease by Assicot et al.(5). Procalcitonin is almost undetectable under physiological conditions (pg/ml range), but rises to very high values in response to bacteraemia or fungaemia, and appears to be related to the severity of infection.(6)  Sequential measurements in patients with bacteraemia have shown a rapid fall within 48 hours of antibiotic administration.

Is it an unlikely candidate sepsis biomarker? It is a precursor of calcitonin, and under ordinary circumstances can be accounted for by its production in the thyroid. It is widely produced extrathyroidally with sepsis. The main reason for such interest is the response seems to be uncoupled to the systemic inflammatory response, as CRP is.  What is it a response to? What is the role it has in primary cellular immune response? There is no question that it is found in very low level without serious infection, so that a low level would remove the necessity for a blood culture. In other words it predicts absence of sepsis. Is it fortuitous or serendipity?

On the other hand, we now refer to bacterial and abacterial sepsis. So there are a significant proportion of sepsis diagnoses for which cultures are negative. You might decide that the method of taking cultures x3 at different times and from different sites (not universally practiced) might account for the negative cultures. It was reported in the New York Times a week ago that a child came to the emergency room in a NY hospital with a simple sports injury abrasing the skin surface, was sent home, returned, and died in 24 hours. It’s not such an easy call, despite the result.

There have been numerous studies of the early recognition of sepsis and related diseases in patients related to admission and intensive care. The consensus  guideline has used a SIRS criteria (7, 8).  The SIRS criteria (7,8)  include temperature o C. >= 38o C., heart rate > 90 beats per minute, respiratory rate >20 breaths per minute or PaCO  < 32 mm of Hg, WBC > 12,000/mL or < 4,000/mL, or > 10% band forms. For the diagnosis of sepsis (2 or more SIRS criteria and confirmed or suspected infection) the SIRS criteria are insufficient with a very high false positive rate, so that there are medical institutions that require three.  The observation of fever, tachypnea, and tachycardia may well not be present early, and the observation of leukocytosis with or without band neutrophilia are unreliable.  The use of a plasma lactic acid measurement has been added, but it is basically a reflection of decreased splanchnic circulation to the superior mesenteric artery and liver bed.  A better case has been made for absolute neutophilia (9), with an adjustment for high lymphocyte counts in children in the first six months, and for the identification of increased immature myeloid precursors (myelocytes and metamyelocytes). The C-reactive protein, a long established acute phase protein, is not predictive at levels under 520 mg/L because it is elevated in a variety of chronic inflammatory conditions.  Moreover, it is infrequently used in adult medical practice for that reason, except for the high sensitivity CRP, which has been shown to be relevant to treatment of coronary heart disease by the Jupiter study (10), but also has raised the question of overuse of the statins with the undesirable side effect of skeletal muscle loss.  We can explore the validity of over ten years of studies in Europe and US, showing a debated benefit from using the procalcitonin biomarker (PCT, Brahms)(11-28).

The question arises whether there is a difference in PCT response between Gm- and Gm+, and there is, but it doesn’t matter. We can’t be certain that this reaction is  produced by vascular endothelium. I could identify at least one case where I knew the patient had no culture taken and died in cardiovascular shock. At that stage of decompensation what would make one think that it was other than pump failure? But in the evolution of cardiogenic shock, the perfusion of the superior mesentery artery could well be decompensated with the release of bacteria of intestinal organs. Quite a bit of work has been done in surgical research that indicates that there is bacterial migration to regional nodes, but it isn’t problematic unless there is a systemic insult.

Then there needs to be an explanation of events related to gene regulation and cell signaling, that is a blank screen. The cost of the test has been a factor limiting the use, which I think is not the key issue.

Results

A multivariable study with 435 patients to determine whether procalcitonin alone is a superior marker for sepsis established a difference between patients with and without sepsis , as the increase in PCT with sepsis was significant at p = 0.0001.  The PCT was also increased in patients who were admitted to the ICU, requiring assisted ventilation and monitoring of heart rate and blood pressure, significant at p = 0.0001.  The highest values occur in septic shock, even though mild elevations are seen with localized infection.  A PCT level distinguishes between four subgroups of the population: no infection, local infection, sepsis, and severe sepsis and septic shock. The PCT is very low with no infection and rises to levels above 5 with moderate to severe sepsis.  Table 1 compares the selected biomarker results for patients in ICU and not in ICU by the t test with adjustment for unequal variances.  The salient points are noted. PCT, not CRP, is significant for a difference between SIRS positive and SIRS negative patients in ICU (p=0.0001 vs 0.166), with a mean CRP of 495 mg/L in non ICU patients.  The result is expected because the CRP is elevated in other conditions without sepsis, and the patients in the ICU and outside the ICU may have a variety of inflammatory conditions.  There is a difference in PCT between ICU and non-ICU patients without SIRS (p = 0.0001), indicating that PCT is identifying infection, if not sepsis, in this cohort of patients.  Patients in the ICU with SIRS (vs without) have a mean PCT of 35.2 vs 3.7 ng/ml, a clinically as well as statistically significant increase in PCT (Mann-Whitney, p = 0.0001). On the other hand, patients without SIRS in the ICU also have higher CRP [1] and PCT [2] than those not in ICU (1, p = 0.032; 2, p = 0.004), but the CRP difference just reaches statistical significance while the unexpected PCT increase is a big effect.  The means obtained for SIRS/non-SIRS are: CRP [1] 802/404 mg/L; PCT [2] 20.6/7.5 ng/ml; TTR [3] 87.8/125 mg/L. So we see an increase of CRP and PCT with SIRS, as expected, and a decrease in TTR to below 100 mg/L as an obligatory response in relationship to the severity of the inflammatory state. The patients with SIRS and those with sepsis, respectively, had significant elevations of CRP [1] and PCT[2], and decrease of TTR[3] by Mann-Whitney test      (SIRS, p = 0.006, CRP [1]; 0.0001, PCT [2]; 0.0001 TTR[3]; sepsis, p = 0.010, CRP [1]; 0.014, PCT [2]; 0.004, TTR [3]).

Finally, we are particularly interested in combinations of variables for predicting infection and the stage of infection using PCT, MAP (mean arterial blood pressure), WBC.  The model fit looks good based on the chi-squared statistics.   The relationship between the predictor variables and SIRS or ICU is consistent with the large increases of PCT described.  In exploring this strong association between the chosen predictors for SIRS and ICU – PCT, WBC, MAP and TTR (CRP not used) demonstrated that each can be used in a classification matrix. (Table 2)   One might create a 4-letter code using M (MAP)_T (TTR)_W (WBC)_S (SIRS) to test for PCT effectiveness in the same way that one would test PCT against the clinical diagnosis of sepsis, but excluding the variable that we are interested in proving.  PCT can then be added as the fifth variable. The data was classified according to mean arterial blood pressure (MAP), TTR, white cell count (WBC), and SIRS as described and the PCT was kept out of the classification.  The PCT, MAP and SIRS differences were all significant at 0.0001, and the TTR had a p = 0.021 in the Kruskall Wallis analysis by ranks. A similar, but simpler classification did not include either PCT or MAP, resulting in three classes. The PCT increased within the subgroups of WTSIRS (2.5, 25, 50, 75 and 97.5 percentiles. Further, the subgroup of patients classified by MAP, TTR, WBC and SIRS, had a dramatic decline in the MAP by subclass, the last of which is comparable to septic shock.   We constructed a latent class model using the ordinals of PCT, MAP and WBC scaled to intervals. The combinatorial classes formed by the predictors have a defined contribution (percent) of each predictor.  The R2, L2 and C2 are shown.

Degrees of freedom (df)            282                  p-value

L-squared (L²)                         217.6904         1.00

X-squared                                235.4391         0.98

Cressie-Read                           209.1484         1.00

aBIC (based on LL)                  634.1041

bAIC (based on LL)                 494.7921

aBayes Information Criterion, bAkaike’s Information Criterion

Model for Dependent

Class1             0.7961

Class2             0.9136

Class3             0.9782

Class4             0.6410

Overall            0.9319

The chi-squared with a p-value close to 1 indicates that the partitioning of the combinatorial groups is excellent, and the model is not underfit or overfit.   A second cluster LCA model using SIRS as covariate also gives a good fit. The p-values are acceptable.

Chi-squared Statistics

Degrees of freedom (df)                        258                  p-value

L-squared (L²)                                     248.9633         0.65

X-squared                                            230.6279         0.89

Cressie-Read                                       222.0675         0.95

BIC (based on L²)                                -1238.4560

AIC (based on L²)                                -267.0367

Even though CRP has validity for identifying SIRS in our exploratory study, the specificity and its usefulness at a cutoff at 52 mg/dL raised significant concerns with respect to with respect to distinguishing SIRS with and without infection.  Keep in mind that large variances in CRP exist between the subgroups, which is problematic because of the CRP elevation in patients with metabolic syndrome and with chronic inflammatory diseases, but not necessarily sepsis. TTR is also decreased, as CRP is elevated, in patients with inflammatory conditions without sepsis.

The data demonstrated a clear relationship between high PCT and both SIRS and the ICU placement of the patient. We also showed the elevation of PCT in concert with severity of infection, as determined by medical record review.  Patients with sepsis are transferred to the ICU for management. These patients are on antibiotics and they are monitored for drop in mean arterial blood pressure over the first 72 hours, as a drop in MAP below 72 indicates septic shock. The progression from SIRS to septic shock goes from single organ (lung, kidney) to double organ, to multiple organ dysfunction syndrome is accompanied by increased lactic acid, tachycardia, decreased MAP, and finally, increase in serum bilirubin.  We would expect and find elevations of PCT with pneumonia, deep wounds, and pyelonephritis as well as sepsis, but these patients would be expected to meet the SIRS criteria.  Our study was not designed to demonstrate how PCT might detect sepsis in older patients with negative SIRS criteria in the ICU who are on ventilator assistance and who may not develop a febrile response. One has to consider that this is related to PCT elevation being partly independent of the SIRS response.

We then showed the same relationship to biomarker combinations that classify the data in accordance with the severity of infection. The WBC count is the weakest classification variable, but it is in the SIRS criteria and it is of greatest value with a finding of immature neutrophils. However, the band count is now considered part of the mature neutrophil count so that the absolute neutrophil count and the immature granulocytes measured by flow cytometry (myelocytes and metamyelocytes) are superior to the tWBC and bands (  ).  The MAP is valuable for identifying the patients at highest risk of circulatory collapse with a drop in the MAP and transfer to ICU (on pressors). The drop in MAP within 72 hours is important for making decisions about Activated protein C (Xygris), which is a critical decision.  APC has been removed from the market.  We included the TTR, which decreases in patients with SIRS in proportion to the severity of illness.  If we compare these predictors in patients with a diagnosis of sepsis, CRP, PCT (and TTR) all have significant differences between ICU and not ICU admission at p < 0.05. The elevation of white cell count and percent neutrophils, unexpectedly has no separatory power. This would not be the case for a postoperative patient who had an increase in WBC that was previously not elevated, or a failure to drop the WBC given antibiotics. On the other hand, for the combination of SIRS and elevated white cell count, the CRP, PCT and TTR all give good separation between ICU and non-ICU patients, an improvement over SIRS positive status alone. This reflects the non specificity with a high false positive rate of the SIRS criteria when neither of the two predictors is granulocytosis.  We asked whether we can combine the key predictor variable into combinatorial classes that would improve the accuracy of identification. CRP was not of interest with respect to this analysis as the poor specificity could only confound matters, and the test offers no additional information than PCT provides.   A more formal classification can then be designed using existing multivariate protocols, but keeping in mind that a mixed model or one using a log-linear model is preferred.

Our study is unique in at least two respects: It is the first to clearly demonstrate a graded response of PCT to severity of infectious challenge.  It is also a rare study to use a classification method to study the effect of combinations of variables associated with SIRS and infection on PCT elevation (11-13). We have created a graded classification by using feature extraction and forming an N-length class based on established information principles (Kullback entropy and Akaike Information Criteria).  The features used to classify the data were PCT, MAP, TTR, WBC and a SIRS score of at least two. The data was also classified without using PCT in order to establish validity for PCT independently of a classification using the feature being evaluated.The classifications have been extensively examined using one-way ANOVA, Kruskal Wallis analysis by ranks,  and latent class analyses. The Kruskal-Wallis analysis by ranks is a powerful tool for comparing the PCT levels within and across feature classes when the variance of PCT values across groups does not have the same distribution and the assumption of normal distribution doesn’t hold. Latent class analysis is a group of methods that can be used to classify data when the data is converted to ordinal classes under the assumption that there is a hidden or “latent” underlying classification. In defining latent classes we assume the criterion of “conditional independence,” so that, each variable is statistically independent of every other variable within each latent class, In our case, latent classes correspond to probabilities for and against the presence of a distinct medical syndrome. In this case we call attention to the classes representing no infection, soft tissue infection, sepsis, and severe sepsis or septic shock.  In reality, the variables used to form the classes are not independent, but they are used as ordinal variables and can be ranked in order of importance in forming a classification. There is a paper of some interest with regard to classification and prediction of severe sepsis that finds PCT, lactic acid and aminoterminal pro B-type natriuretic peptide correlating with sepsis severity scores (12) and another using PCT in combination with waveform analysis (13).  Classification and prediction has been of particular interest to the corresponding investigator for laboratory procedure validation for more than 10 years (20-22).  We provide valuable references to this approach (23-27).

In all respects, we find agreement with a large number of studies, including those recently cited (5-19). PCT has been shown to be useful for discriminating systemic inflammatory response, infection and sepsis (5,6) and identifying a high mortality subgroup with sepsis (15), for identifying sepsis at the onset with either gram negative or gram positive bacteremia (10), for evaluating time to treatment effectiveness (16), and for identifying sepsis in the febrile neutropenic patient (18).

What is it in our findings that makes the results compelling?  CRP has been used for many years, although more widely in European countries than in US until the high sensitivity assay association with risk of coronary artery disease generated a new interest in this test.  CRP increase is associated with SIRS and its production is driven by the cytokines TNFa and Il6.  The liver reprioritises the production of acute phase reactants (CRP, a1 acid glycoprotein [orosomucoid], a1 antitrypsin and transferrin with down-regulation of production of albumin, TTR, transcortin, and other serum transport proteins. However, if this happens in the extreme condition, it also is the case in the more chronic conditions, such as, rheumatoid arthritis and autoimmune diseases, and is a feature of the metabolic syndrome, characterized by type 2 diabetes, obesity, and insulin resistance with or without dyslipidemia. Consequently, CRP is quite high associated with a variety of non-septic conditions.  The emergence of PCT as a sepsis biomarker is somewhat serendipidous.  The protein is the precursor of the peptide calcitonin, produced in the thyroid.  Sepsis appears to upregulate the extrathyroidal production of procalcitonin by vascular endothelium by a mechanism not understood.  PCT can be elevated with non-septic shock, such a cardiogenic shock, but it is easy to comprehend that secondary sepsis could occur by loss of gut integrity and bacterial translocation in such a state.

The importance of pneumonia and pyelonephritis as a precursor of sepsis, and the rapid progression of sepsis in the hospitalised ICU patient can’t be taken lightly.  The identification of sepsis in the emergency room is problematic because the clinical presentation is variable and not so specific.  The SIRS criteria – tachycardia, tachypnea, fever, and leukocytosis – are all common presentations in patients without sepsis.   On the one hand, more accurate identification of the patients with sepsis should eliminate many patients who are screened for sepsis and subsequently have negative culture, and should identify patients who require prompt antimicrobial treatment at an early stage.

The progression from SIRS to sepsis to organ failure and septic shock should also be monitored effectively, which depends on the level of PCT reflecting the level of systemic disorder.  This would permit the best identification of patients who are improving and those who might require activated protein C intervention.  The progression from SIRS to sepsis and beyond is a complex process involving repeated events in the course of the acute illness.  This gives even more justification for combining PCT with other measures to manage the septic state.

Conclusion

We have demonstrated a clear relationship between high PCT and both SIRS and the ICU placement of the patient.  In addition, we have shown the strength of classifying these patients using PCT in combination with MAP, TTR, WBC and SIRS.

References

1. Martin MS, Mannino DM, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003; 348:1546-1554.

2. NationalCenter for Health Statistics. National vital statistics reports. 2004; 53:9.

3. Angus DC, Linde-Zwirble WT, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29:1303-1310.

4.  Smith BS, Schroeder WS; Tataronis GR.Hospital reimbursement for adult Patients with severe sepsis treated with drotrecogin alfa (activated). Hospital pharmacy 2005; 40:146-153.

5.  Assicot M, Gendrel D, Cersin H, Raymond J, et al. High serum procalcitonin concentrations in patients withsepsis and infection.  Lancet 1993: 341: 515-18.

6.  Delveraux I, Andre M, Columbier M, Albuisson E, et al. Can procalcitonin measurement help in differentiating between bacterial and other kinds of inflammatory processes?  Ann Rheum Dis 2003; 62: 337-40.

7. Bone R, Balk R, Cerra F, Dellinger R, Fein W, et. Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Amer Coll of Chest Physicians/Soc of Critical Care Med. Chest 1992; 101(6): 1644-655.

8.Dellinger R, Phillip R, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: Internatl Guidelines for Management of Severe Sepsis and Septic Shock:2008. Crit Care Med 2008; 36(1): 296-377.

9. Bernstein LH and Rucinski R. The relationship between granulocyte maturation and the septic state measurement of granulocyte maturation may improve the early diagnosis of the septic state.  Clin Chem Lab Med 2011;         DOI 10.1515/CCLM.2011.xxx

10. Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM, et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.  NEJM 2008; 359: 2195-2207.

11. Jensen JU, Heslet L,; Jensen TH, Espersen K, et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006; 34(10):1-7.

12.  Luzzani A, Polati E, Dorizzi R, Rungatscher A, et al.  Comparison of procalcitonin and C-reactive protein as markers of sepsis. Critical Care Medicine 2003:31(6):1737-1741.

13.  Reith HB, Mittelkotter U, Wagner R, Thiede A. Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Med 2000; 26 suppl2: S165-9.

14.  Rau B, Steinbach G, Baumgart K, Gansauge F, et al. The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis. Intensive Care Med 2000; 26, suppl2. S159-64.

15.  Cheval C, Timsit JF, Garrouste-Orgeas M, Assicot M, et al. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients. Intensive Care Med 2000; 26, suppl2 S153-8.

16.  Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 2000; 26, suppl2 S148-52.

17.  Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008; 36(3): 941-52.

18.  Charles PE, Ladoire S, Aho S, Quenot JP, Doise JM, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infectious Diseases 2008, 8:38 (http://www.biomedcentral.com/1471-2334/8/38)

19.  Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W.  Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Critical Care Medicine. 2000; 28(4): 950-957.

20.   Harbath S, Holeckova K, Froidevaux C, Pittet D, et al. Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients Admitted with Suspected Sepsis. Amer J Respir Crit Care Med 2001;164: 396-402.

21.   Simon L, Gauvin F, 2 Devendra K. Amre DK,Saint-Louis P, Lacroix J. Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis. CID 2004: 39:206-217.

22.   Selberg O, Hecker H, Martin M, Klos A Bautsch, et al.  Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Critical Care Medicine. 2000; 28(8): 2793-2798.

23.   Phua J, Koay ES, Lee KH. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock 2008; 29(3):328-33.

24.   Zakariah AN ; Cozzi SM ; Van Nuffelen M ; Clausi CM ; Pradier O ; Vincent JL. Combination of biphasic transmittance waveform with blood procalcitonin levels for diagnosis of sepsis in acutely ill patients. Crit Care Med.  2008; 36(5): 1507-12

25.   Viallon A, Guyomarch S, Marjollet O, Berger C, et al. Can Emergency physicians identify a high mortality subgroup of patients with sepsis: role of procalcitonin? Eur J Emerg Med 2008; 15(1):26-33.

26.   Bobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008;177 (5):498-505.

27.   Indino P, Lemarchand P, Bady P, de Torrente A, et al. Prospective study on procalcitonin and other systemic infection markers in patients with leukocytosis. Int J Infect Dis 2008;12 (3):319-24.

The role of biomarkers in the diagnosis of sepsis and patient management
Author: L. H. Bernstein, MD
Key words: Systemic Inflammatory Response Syndrome (SIRS), sepsis, septic shock, mean arterial blood pressure (MAP), procalcitonin, combinatorial analysis, effect size
Highlights:
1. The systemic inflammatory response syndrome (SIRS) is an acute response to trauma, burn, or infectious injury characterized by fever, hemodynamic and respiratory changes, and metabolic changes, not all of which are consistently present.
2. The SIRS reaction involves hormonally driven changes in liver glycogen reserves, triggering of lipolysis, lean body proteolysis, and reprioritization of hepatic protein synthesis with up-regulation of synthesis of acute phase proteins and down-regulation of albumin and important circulating transport proteins.
3. Understanding of the processes leads to the identification of biomarkers for identification of sepsis and severe, moderate or early SIRS, which also can hasten treatment and recovery.
4. The SIRS reaction unabated leads to a recurring cycle with hemodynamic collapse from septic shock, indistinguishable from cardiogenic shock, and death.

Abbreviations: Systemic Inflammatory Response Syndrome (SIRS), procalcitonin (PCT), C-reactive protein (CRP), mean arterial blood pressure (MAP), Intensive care unit (ICU), total white blood cell count (WBC), transthyretin(TTR)

Summary
By focusing on early and accurate diagnosis of infection in patients suspected of SIRS antibiotic overuse and its associated morbidity and mortality may be avoided, and therapeutic targets may be identified. This discussion investigates the performance of diagnostic algorithms and biomarkers for sepsis in patients presenting with leukocytosis and other findings. Suspected patients are usually identified by WBC above 12,000/L PCT level , SIRS and other criteria, such as serum biomarkers of sepsis. In this writer’s study of 435 patients, procalcitonin alone was a superior marker for sepsis. In patients with sepsis there was a marked increase in PCT (p = 0.0001). PCT was increased in patients requiring ICU admission, heart rate and blood pressure monitoring, and assisted ventilation.(p = 0.0001). Means for SIRS/non-SIRS were: CRP 802/404 mg/L; PCT 20.6/7.5 ng/mL; TTR 87.8/125 mg/L. A comprehensive overview of at least a decade of work is provided.

Introduction
Sepsis is a costly diagnosis in hospitalized patients and carries a high financial risk as a comorbidity and a payment penalty for failure to diagnose in a timely manner (1-4) under the severity of illness CMS reimbursement guidelines as a patient safety hazard, with pneumonia and sepsis among the ten most costly among hospital admissions. A polypeptide identical to a prohormone of calcitonin, procalcitonin, was initially described as a potential marker of bacterial disease by Assicot et al.(5). Procalcitonin is almost undetectable under physiological conditions (pg/ml range), but rises to very high values in response to bacteraemia or fungaemia, and appears to be related to the severity of infection.(6) Sequential measurements in patients with bacteraemia have shown a rapid fall within 48 hours of antibiotic administration. There have been numerous studies of the early recognition of sepsis and related diseases in patients related to admission and intensive care. The consensus
guideline has used a SIRS criteria (7, 8). The SIRS criteria (7,8) include temperature </= 36o C. >= 38o C., heart rate > 90 beats per minute, respiratory rate >20 breaths per minute or PaCO2 < 32 mm of Hg, WBC > 12,000/L or < 4,000/L, or > 10% band forms. For the diagnosis of sepsis (2 or more SIRS criteria and confirmed or suspected infection) the SIRS criteria are insufficient with a very high false positive rate, so that there are medical institutions that require three. The observation of fever, tachypnea, and tachycardia may well not be present early, and the observation of leukocytosis with or without band neutrophilia are unreliable. The use of a plasma lactic acid measurement has been added, but it is basically a reflection of decreased splanchnic circulation to the superior mesenteric artery and liver bed. A better case has been made for absolute neutophilia (9), with an adjustment for high lymphocyte counts in children in the first six months, and for the identification of increased immature myeloid precursors (myelocytes and metamyelocytes). The C-reactive protein, a long established acute phase protein, is not predictive at levels under 520 mg/L because it is elevated in a variety of chronic inflammatory conditions. Moreover, it is infrequently used in adult medical practice for that reason, except for the high sensitivity CRP, which has been shown to be relevant to treatment of coronary heart disease by the Jupiter study (10), but also has raised the question of overuse of the statins with the undesirable side effect of skeletal muscle loss. We can explore the validity of over ten years of studies in Europe and US, showing a debated benefit from using the procalcitonin biomarker (PCT, Brahms)(11-28).
Results
A multivariable study with 435 patients to determine whether procalcitonin alone is a superior marker for sepsis established a difference between patients with and without sepsis , as the increase in PCT with sepsis was significant at p = 0.0001. The PCT was also increased in patients who were admitted to the ICU, requiring assisted ventilation and monitoring of heart rate and blood pressure, significant at p = 0.0001. The highest values occur in septic shock, even though mild elevations are seen with localized infection. A PCT level distinguishes between four subgroups of the population: no infection, local infection, sepsis, and severe sepsis and septic shock. The PCT is very low with no infection and rises to levels above 5 with moderate to severe sepsis. Patients in the ICU with SIRS (vs without) have a mean PCT of 35.2 vs 3.7 ng/ml, a clinically as well as statistically significant increase in PCT (Mann-Whitney, p = 0.0001). On the other hand, patients without SIRS in the ICU also have higher CRP [1] and PCT [2] than those not in ICU (1, p = 0.032; 2, p = 0.004), but the CRP difference just reaches statistical significance while the unexpected PCT increase is a big effect. The means obtained for SIRS/non-SIRS are: CRP [1] 802/404 mg/L; PCT [2] 20.6/7.5 ng/ml; TTR [3] 87.8/125 mg/L. So we see an increase of CRP and PCT with SIRS, as expected, and a decrease in TTR to below 100 mg/L as an obligatory response in relationship to the severity of the inflammatory state. The patients with SIRS and those with sepsis, respectively, had significant elevations of CRP [1] and PCT[2], and decrease of TTR[3] by Mann-Whitney test (SIRS, p = 0.006, CRP [1]; 0.0001, PCT [2]; 0.0001 TTR[3]; sepsis, p = 0.010, CRP [1]; 0.014, PCT [2]; 0.004, TTR [3]).
Finally, we are particularly interested in combinations of variables for predicting infection and the stage of infection using PCT, MAP (mean arterial blood pressure), WBC. The model fit looks good based on the chi-squared statistics.

Degrees of freedom (df) 282 p-value
L-squared (L²)       217.69       1.00
X-squared                235.44       0.98
Cressie-Read           209.15       1.00

aBIC (based on LL)      634
bAIC (based on LL)     495
aBayes Information Criterion, bAkaike’s Information Criterion

Model for Dependent
Class1    Class2       Class3    Class4     Overall
R² 0.7961    0.9136    0.9782   0.6410   0.9319

The chi-squared with a p-value close to 1 indicates that the partitioning of the combinatorial groups is excellent, and the model is not underfit or overfit. A second cluster LCA model using SIRS as covariate also gives a good fit. The p-values are acceptable.
Chi-squared Statistics
Degrees of freedom (df) 258      p-value
L-squared (L²)              248.96      0.65
X-squared                       230.62      0.89
Cressie-Read                  222.07     0.95
BIC (based on L²)       -1238.46
AIC (based on L²)        -267.04
Even though CRP has validity for identifying SIRS in our exploratory study, the specificity and its usefulness at a cutoff at 52 mg/dL raised significant concerns with respect to with respect to distinguishing SIRS with and without infection. Keep in mind that large variances in CRP exist between the subgroups, which is problematic because of the CRP elevation in patients with metabolic syndrome and with chronic inflammatory diseases, but not necessarily sepsis. TTR is also decreased, as CRP is elevated, in patients with inflammatory conditions without sepsis.
The data demonstrated a clear relationship between high PCT and both SIRS and the ICU placement of the patient. We also showed the elevation of PCT in concert with severity of infection, as determined by medical record review PWe would expect and find elevations of PCT with pneumonia, deep wounds, and pyelonephritis as well as sepsis, but these patients would be expected to meet the SIRS criteria. Our study was not designed to demonstrate how PCT might detect sepsis in older patients with negative SIRS criteria in the ICU who are on ventilator assistance and who may not develop a febrile response. One has to consider that this is related to PCT elevation being partly independent of the SIRS response.
We then showed the same relationship to biomarker combinations that classify the data in accordance with the severity of infection. The WBC count is the weakest classification variable, but it is in the SIRS criteria and it is of greatest value with a finding of immature neutrophils. However, the band count is now considered part of the mature neutrophil count so that the absolute neutrophil count and the immature granulocytes measured by flow cytometry (myelocytes and metamyelocytes) are superior to the tWBC and bands ( ). The MAP is valuable for identifying the patients at highest risk of circulatory collapse with a drop in the MAP and transfer to ICU (on pressors). The drop in MAP within 72 hours is important for making decisions about Activated protein C (Xygris), which is a critical decision. APC has been removed from the market. We included the TTR, which decreases in patients with SIRS in proportion to the severity of illness. We asked whether we can combine the key predictor variable into combinatorial classes that would improve the accuracy of identification. CRP was not of interest with respect to this analysis as the poor specificity could only confound matters, and the test offers no additional information than PCT provides.
Our study is unique in at least two respects: It is the first to clearly demonstrate a graded response of PCT to severity of infectious challenge. It is also a rare study to use a classification method to study the effect of combinations of variables associated with SIRS and infection on PCT elevation (11-13). We have created a graded classification by using feature extraction and forming an N-length class based on established information principles (Kullback entropy and Akaike Information Criteria). The features used to classify the data were PCT, MAP, TTR, WBC and a SIRS score of at least two. The data was also classified without using PCT in order to establish validity for PCT independently of a classification using the feature being evaluated.The classifications have been extensively examined using one-way ANOVA, Kruskal Wallis analysis by ranks, and latent class analyses. The Kruskal-Wallis analysis by ranks is a powerful tool for comparing the PCT levels within and across feature classes when the variance of PCT values across groups does not have the same distribution and the assumption of normal distribution doesn’t hold. Latent class analysis is a group of methods that can be used to classify data when the data is converted to ordinal classes under the assumption that there is a hidden or “latent” underlying classification. In defining latent classes we assume the criterion of “conditional independence,” so that, each variable is statistically independent of every other variable within each latent class, In our case, latent classes correspond to probabilities for and against the presence of a distinct medical syndrome. In this case we call attention to the classes representing no infection, soft tissue infection, sepsis, and severe sepsis or septic shock. In reality, the variables used to form the classes are not independent, but they are used as ordinal variables and can be ranked in order of importance in forming a classification. There is a paper of some interest with regard to classification and prediction of severe sepsis that finds PCT, lactic acid and aminoterminal pro B-type natriuretic peptide correlating with sepsis severity scores (12) and another using PCT in combination with waveform analysis (13). Classification and prediction has been of particular interest to the corresponding investigator for laboratory procedure validation for more than 10 years (20-22). We provide valuable references to this approach (23-27).
In all respects, we find agreement with a large number of studies, including those recently cited (5-19). PCT has been shown to be useful for discriminating systemic inflammatory response, infection and sepsis (5,6) and identifying a high mortality subgroup with sepsis (15), for identifying sepsis at the onset with either gram negative or gram positive bacteremia (10), for evaluating time to treatment effectiveness (16), and for identifying sepsis in the febrile neutropenic patient (18).
We have demonstrated a clear relationship between high PCT and both SIRS and the ICU placement of the patient. In addition, we have shown the strength of classifying these patients using PCT in combination with MAP, TTR, WBC and SIRS.

References

1. Martin MS, Mannino DM, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003; 348:1546-1554.
2. National Center for Health Statistics. National vital statistics reports. 2004; 53:9.
3. Angus DC, Linde-Zwirble WT, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29:1303-1310.
4. Smith BS, Schroeder WS; Tataronis GR. Hospital reimbursement for adult Patients with severe sepsis treated with drotrecogin alfa (activated). Hospital pharmacy 2005; 40:146-153.
5. Assicot M, Gendrel D, Cersin H, Raymond J, et al. High serum procalcitonin concentrations in patients withsepsis and infection. Lancet 1993: 341: 515-18.
6. Delveraux I, Andre M, Columbier M, Albuisson E, et al. Can procalcitonin measurement help in differentiating between bacterial and other kinds of inflammatory processes? Ann Rheum Dis 2003; 62: 337-40.
7. Bone R, Balk R, Cerra F, Dellinger R, Fein W, et. Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Amer Coll of Chest Physicians/Soc of Critical Care Med. Chest 1992; 101(6): 1644-655.
8.Dellinger R, Phillip R, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: Internatl Guidelines for Management of Severe Sepsis and Septic Shock:2008. Crit Care Med 2008; 36(1): 296-377.
9. Bernstein LH and Rucinski R. The relationship between granulocyte maturation and the septic state
measurement of granulocyte maturation may improve the early diagnosis of the septic state. Clin Chem Lab Med 2011; DOI 10.1515/CCLM.2011.xxx
10. Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. NEJM 2008; 359: 2195-2207.
11. Jensen JU, Heslet L,; Jensen TH, Espersen K, et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006; 34(10):1-7.
12. Luzzani A, Polati E, Dorizzi R, Rungatscher A, et al. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Critical Care Medicine 2003:31(6):1737-1741.
13. 2008, 8:38 (http://www.biomedcentral.com/1471-2334/8/38)
19. Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Critical Care Medicine. 2000; 28(4): 950-957.
20. Harbath S, Holeckova K, Froidevaux C, Pittet D, et al. Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically Ill Patients Admitted with Suspected Sepsis. Amer J Respir Crit Care Med 2001;164: 396-402.
21. Simon L, Gauvin F, 2 Devendra K. Amre DK,Saint-Louis P, Lacroix J. Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis.
CID 2004: 39:206-217.
22. Selberg O, Hecker H, Martin M, Klos A Bautsch, et al. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Critical Care Medicine. 2000; 28(8): 2793-2798.
23. Phua J, Koay ES, Lee KH. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock 2008; 29(3):328-33.
24. Zakariah AN ; Cozzi SM ; Van Nuffelen M ; Clausi CM ; Pradier O ; Vincent JL. Combination of biphasic transmittance waveform with blood procalcitonin levels for diagnosis of sepsis in acutely ill patients. Crit Care Med. 2008; 36(5): 1507-12
25. Viallon A, Guyomarch S, Marjollet O, Berger C, et al. Can Emergency physicians identify a high mortality subgroup of patients with sepsis: role of procalcitonin? Eur J Emerg Med 2008; 15(1):26-33.
26. Bobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008;177 (5):498-505.
27. Indino P, Lemarchand P, Bady P, de Torrente A, et al. Prospective study on procalcitonin and other systemic infection markers in patients with leukocytosis. Int J Infect Dis 2008;12 (3):319-24.
28. Massaro KS, Costa SF, Leone C, Chamone DA. Procalcitonin (PCT) and C-reactive Protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis 2007; 22(7): 137 (http://www.biomedcentral.com/1471-2334-7-137).
29. Vermunt J and Magidson J. Latent Gold 4.5. http://www.statistical.innovations.com

Table 1. Comparison of key sepsis biomarkers by means between ICU and non-ICU, SIRS positive status, and sepsis status.

Marker

Mean

p

SIRS Positive

ICU vs not

CRP (mg/L) 780 495 0.166
PCT (ng/ml) 35.2 3.7 0.0001

SIRS negative

ICU vs not

PCT (ng/ml) 0.0001

Sepsis Diagnosis

ICU vs not

CRP (mg/L) 817 521 0.010
PCT (ng/ml) 0.014
WBC 0.921
% neutrophils 0.452

SIRS with WBC

ICU vs not

CRP (mg/L) 802 404 0.006
PCT (ng/ml) 20.6 7.5 0.0001

Table 2. Comparison of PCT, MAP, TTR and WBC means and variation in SIRS and ICU placement.

variable-by-variablea

Fisher’s Exact testb

t-testc

PCT*SIRS

0.0001

0.0210

PCT*ICU

0.0001

0.0001

MAP*SIRS

0.0130

MAP*ICU

0.0001

0.0001

WBC*SIRS

0.0001

0.0001

WBC*ICU

NS

TTR*SIRS

0.0001

0.0001

TTR*ICU

0.0001

atwo variables, b,cp-value

Archival Table

Table 3.  Classes and 4-variable contributions for 4-class LCA cluster model.

Cluster Size

0.3646             0.2738             0.2209             0.1408

Indicators

PCT0425         (PCT: < 0.4, 0.41-2.5, > 2.5)

0          0.6393             0.8894             0.1278             0.0000

1          0.3190             0.1076             0.3752             0.0013

2          0.0355             0.0029             0.2459             0.0285

3          0.0062             0.0001             0.2511             0.9702

MAP758088    (MAP: > 88, 81-87, 75-80, < 80)

0          0.5234             0.6186             0.3709             0.4228

1          0.1861             0.1794             0.1771             0.1828

2          0.1065             0.0838             0.1361             0.1272

3          0.1841             0.1181             0.3160             0.2673

WBC1217       (WBC: < 12, 12-17, > 17)

0          0.3325             0.1772             0.0002             0.3084

1          0.4152             0.3948             0.0216             0.4171

2          0.2523             0.4280             0.9782             0.2745

TTR7105         (TTR: > 10.5, 7.0-10.5, < 7)

0          0.2457             0.9805             0.2159             0.3920

1          0.3352             0.0192             0.3279             0.3391

2          0.4191             0.0003             0.4562             0.2688

            Table 1. Comparison of key sepsis biomarkers by means between ICU and non-ICU, SIRS positive status, and sepsis status.

Marker

Mean

p

SIRS Positive

ICU vs not

CRP (mg/L) 780 495 0.166
PCT (ng/ml) 35.2 3.7 0.0001

SIRS negative

ICU vs not

PCT (ng/ml) 0.0001

Sepsis Diagnosis

ICU vs not

CRP (mg/L) 817 521 0.010
PCT (ng/ml) 0.014
WBC 0.921
% neutrophils 0.452

SIRS with WBC

ICU vs not

CRP (mg/L) 802 404 0.006
PCT (ng/ml) 20.6 7.5 0.0001

Table 2. Comparison of PCT, MAP, TTR and WBC means and variation in SIRS and ICU placement.

variable-by-variablea

Fisher’s Exact testb

t-testc

PCT*SIRS

0.0001

0.0210

PCT*ICU

0.0001

0.0001

MAP*SIRS

0.0130

MAP*ICU

0.0001

0.0001

WBC*SIRS

0.0001

0.0001

WBC*ICU

NS

TTR*SIRS

0.0001

0.0001

TTR*ICU

0.0001

atwo variables, b,cp-value

Archival Table

Table 3.  Classes and 4-variable contributions for 4-class LCA cluster model.

Cluster Size

0.3646             0.2738             0.2209             0.1408

Indicators

PCT0425         (PCT: < 0.4, 0.41-2.5, > 2.5)

0          0.6393             0.8894             0.1278             0.0000

1          0.3190             0.1076             0.3752             0.0013

2          0.0355             0.0029             0.2459             0.0285

3          0.0062             0.0001             0.2511             0.9702

MAP758088    (MAP: > 88, 81-87, 75-80, < 80)

0          0.5234             0.6186             0.3709             0.4228

1          0.1861             0.1794             0.1771             0.1828

2          0.1065             0.0838             0.1361             0.1272

3          0.1841             0.1181             0.3160             0.2673

WBC1217       (WBC: < 12, 12-17, > 17)

0          0.3325             0.1772             0.0002             0.3084

1          0.4152             0.3948             0.0216             0.4171

2          0.2523             0.4280             0.9782             0.2745

TTR7105         (TTR: > 10.5, 7.0-10.5, < 7)

0          0.2457             0.9805             0.2159             0.3920

1          0.3352             0.0192             0.3279             0.3391

2          0.4191             0.0003             0.4562             0.2688

Read Full Post »